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Abstract 
This study assessed the effectiveness of specific elements of an innovative 
colonoscopy clinical protocol, namely use of a hands-on 2-person technique (vs. solo 
performance) and use of propofol sedation in enhancing the performance quality of 
screening colonoscopies by trained primary care physicians (PCP) and specialists. The 
study used data from a state-licensed ambulatory surgery center for endoscopy in South 
Carolina from September 4, 2001 to February 4, 2011. This center has trained 54 PCPs in 
colonoscopy performance since 2001. Post training, PCPs are credentialed to perform 
colonoscopy only with the 2-person technique with a specialist available onsite to provide 
rescue assistance. A total of 59 physicians performed colonoscopies, and 57 physicians 
(54 PCPs and 3 specialists) consistently complied with the 2-person technique, while 2 
non PCPs (one colorectal surgeon and one general surgeon) used the conventional solo 
performance technique. Propofol sedation in lieu of the conventionally used midazolam-
meperidine (MM) sedation was implemented since April 1, 2006.  
The dependent variables of interest representing procedure quality were as 
follows: procedure time, the likelihood of finding a/an polyp/adenoma/advanced 
neoplasm, finding an additional polyp/adenoma, finding at least one right-sided polyp, 
and finding increasingly smaller polyps. These quality indicators were found to be 
positively associated with the 2-person technique protocol. There was a marginal gain on 
some of the measures with the use of propofol sedation. The findings suggest that the 2-
person technique as implemented by this center improves the global quality of 
v 
colonoscopy performance on measures that are documented to predict colorectal cancer 
prevention effectiveness.  
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Chapter 1 RESEARCH BACKGROUND AND SIGNIFICANCE 
This chapter describes the background and the significa ce of the study topic. 
1.1  Study Background 
Colorectal cancer (CRC) is the third most prevalent cancer and second leading 
cause of cancer death in the U.S. (U.S. Cancer Statistics Working Group), with 
almost140, 000 new cases and 55,000 deaths annually. This large number affected can be 
mostly prevented by screening tests both by removing pre-cancerous lesions and by early 
detection. In the past decade, age-adjusted CRC incide e decreased from 51.8 per 
100,000 in 1999 to 44.7 per 100,000 in 2009; as well as age-adjusted CRC mortality, 
which decreased from 20.5 per 100,000 to 16.9 per 100,000 (SEER 1990-2010).  
Despite some degree of annual reductions in CRC incide e and mortality, CRC 
remains a major threat to public health when compared to the motor vehicle accident 
fatality rate of about 11 per 100,000 annually (NHTSA 2012). Evidence indicates that 
screening tests, such as fecal occult blood test (FOBT) and fecal immunochemical test 
(FIT), sigmoidoscopy, and colonoscopy etc, availed at appropriate intervals, can reduce 
the risk of CRC to some extent by enabling the early detection and removal of advanced 
polyps. The American Cancer Society in 1992 and the U.S. Preventive Services Task 
Force (USPSTF) in 1996 initiated the earliest guidelines recommending CRC screening 
of average risk individuals, who are aged 50 years and older to undergo routine 
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screenings until the age of 75. Currently, the USPSTF recommended screening 
tests and intervals are: 
• Annual screening with high-sensitivity fecal occult blood testing 
• Sigmoidoscopy every 5 years, with high-sensitivity fecal occult blood testing 
every 3 years 
• Colonoscopy every 10 years 
Colonoscopies have been recommended as the preferred scr ening method, 
including the American College of Obstetricians and Gynecologists, the American 
College of Gastroenterology (Rex 2000, Rex 2009) and the American Society for 
Gastrointestinal Endoscopy (ASGE) (David 2006). Although colonoscopy every 10 years 
is considered to be the preferred screening method, it is imperfect because of variable 
quality of screening colonoscopy under community-based practice conditions. 
As the use of colonoscopy screening increases, the need for measurement of 
colonoscopy quality is inevitable to ensure quality in the performance of colonoscopies. 
Generally, the cecal intubation rate is most commonly studied. However, this is a very 
limited measure of quality, and widespread poor quality of colonoscopy performance 
continues to limit the CRC prevention potential.  
Adenoma detection and removal is the mechanism of conferring CRC prevention 
and is the main goal of colonoscopy, and should be a k y indicator for assessing 
colonoscopy quality. Among endoscopists a wide range of the adenoma detection rate 
(ADR) has been documented (Millan 2008, Barclay 2006, Wilkins 2009, Rex 2001). This 
implies that the quality of colonoscopies varies widely, which could reduce its efficacy in 
CRC protection. A meta-analysis of 12 studies focusing on colonoscopies performed by 
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primary care physicians (PCPs) with a total of 18,292 patients found an adenoma 
detection rate of 28.9%. The authors concluded that colonoscopy performance by PCPs 
can meet the professional, societies’ recommended standards (Wilkins 2009). The 
association between colonoscope withdrawal times and adenoma detection rates was also 
studied. Barclay (2006) reported that physicians who had a mean withdrawal time less 
than 6 minutes (when no polyp was found) have an ade oma detection rate of 11.8%, 
while it was 28.3% for those with a mean withdrawal time of more than 6 minutes. This 
statistically significant difference persists in the next level of quality, the mean number of 
adenomas per subject, which were 0.17 vs. 0.61, respectively. Rex et al (2001) 
videotaped 10 procedures performed by 2 colonoscopits and got them reviewed/scored 
by 4 experts based on four quality criteria related to colonoscopic withdrawal technique. 
They reported that technique does matter to the adenoma miss rate, which could be 
further associated with the potential cancer protection efficacy of colonoscopy screening. 
There is concern about colonoscopy quality because of the variable results and outcomes 
in terms of CRC prevention in the literature. Also, c lonoscopy is a physician-dependent 
procedure. To make sure that physicians are doing a good job is more important than how 
many they have carried out. 
In this study, our setting is a community-based facility, which has followed a 
uniform protocol for almost all but not all physicians for 12 years. To evaluate the 
protocol elements, we explore the association between the quality of colonoscopy 
outcomes and two protocol elements, the 2-person technique pioneered by this center, 
and sedation type. 
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1.2  Objectives 
The aim of this study was to evaluate the quality of colonoscopies. Of the risk 
factors which impact colonoscopy performance, our variables of interest were the clinical 
procedure protocol type and the sedation type. We test d the impact of the protocol type 
and the sedation type on the polyp/adenoma detection rate, the mean number of 
polyps/adenomas detected, polyp size, polyp location, and the procedure time. 
We hypothesized that colonoscopy quality may be enhanced by applying the 2-
person technique protocol relative to solo performance, and with deep sedation by 
propofol relative to the conventional Midazolam-meperidine combination. 
The hypotheses tested are: 
1. The screening colonoscopy quality of physicians using the 2-person technique yields 
more adenomas than with solo performers. 
2. The screening colonoscopy quality of procedures with deep sedation by propofol 
yields more adenomas than with the conventional Midazolam-meperidine 
combination. 
1.3  Significance of the research and methodology 
Although colonoscopy is considered to be the reference gold standard against 
which the sensitivity of other colorectal cancer screening tests is compared, it is not 
perfect. Most of the evidence about the sensitivity of a colonoscopy comes from 
experienced examiners conducting study colonoscopies in research settings without 
detailed documentation on the protocol followed. 
The innovative protocol at the community-based endoscopy center (hereafter 
referred to as “Study Center” or “Center”) has the following unique features: a) a hands-
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on 2-person technique, in which the endoscopy technician advances the colonoscope 
while the physician manipulates the scope tip for poly  search and removal, b) propofol 
sedation to substitute the conventional midazolam-meperidine (MM) combination 
sedation starting in April 2006, and c) gradual insertion and withdrawal with polyp search 
and removal during both phases to maximize coverage of the colonic mucosal surface. 
The hands-on 2-person technique method avoids missing polyps due to physician's motor 
fatigue, confers the dexterity of two “right” hands for polyp search and removal, and 
ensures more persons (at least 3 persons, the third being the note taker ) watching the 
video screen for polyps (avoiding visual error). Of these elements, item (a) was not 
followed by experts and some specialists, which enables study of the contribution of the 
hands on 2-person technique. Item (b), propofol sedation was implemented from April 
2006 onwards, enabling pre- and post-comparison to assess the role of propofol sedation. 
This research aims to contribute to the literature by: 
1. Using clinical data for the analysis 
2. Studying a state-of-the-art colonoscopy protocol, which has been applied for over 10 
years 
3. Identifying the effect of protocol elements on screening colonoscopy quality 
4. Analyzing differences in adenoma detection rates by edation type and number of 
persons engaged in procedure performance. 
1.4  Limitations 
1. This clinical dataset is from a single endoscopy center in South Carolina, as such the 
observed findings may not generalize to the other settings. 
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2. Due to the strict implementation of a uniform protocol at this center, the vast 
majority of the procedures were under state-of-the-art protocol. Only 2% of the 
procedures were performed using the conventional industry practice of a one-person 
technique, compared to 98% of procedures performed with the 2-person technique 
distributed across 57 physicians. Therefore the obsrved results may not generalize 
to all physicians using the 1-person technique.  
1.5  Conclusions 
This study finds that an innovation of a hands-on 2-person technique is highly 
associated with superior colonoscopy performance and lesion detection outcomes. By 
every sensitive measure, the results with the 2-person technique are superior and 
consistent across measures. Regarding sedation type, we find that while there is a 
suggestion of a positive association of propofol sedation with improved lesion detection 
and clearance as measured by sensitive indicators, the results did not attain statistical 
significance except in respect of one indicator, the advanced adenoma detection rate. 
Another important indicator for logistic reasons is the procedure time. Because propofol 
induces rapid and deep sedation, as anticipated the study showed a mean reduction in 
procedure time adjusted for all other variables that m y impact procedure time. Our 
findings suggest that propofol sedation may contribu e marginally to improved 
colonoscopy quality. Our study also finds that quality improvement efforts may be more 
productive if focused on measures to improve patients’ bowel preparation status through 
efforts directed at patients, for example, through patient navigation. Regarding propofol 
sedation itself, our findings indicate that endoscopist’s decisions to adopt propofol 
sedation should be guided by considerations of patient comfort and satisfaction, and of 
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the efficiency of endoscopist time utilization rather than an expectation of improved 
lesion detection rates. Our study does not provide support for adoption of propofol 




Chapter 2 LITERATURE REVIEW  
This chapter reviews the related colorectal cancer s reening literature and makes 
the case for the significance of this study based on past research.  
2.1  Overview of colorectal cancer in the United States 
2.1.1 Incidence and mortality 
Approximately 7.6 million people die of cancer each year. These deaths account 
for 13% of all deaths, and 64% occur in the developing countries. The burden of cancer is 
increasing both in the developed and developing countries due to the growth of 
population, aging, and changes in lifestyle, especially for the cancer-associated behaviors, 
such as obesity, smoking, and adoption of Western-style diets. (Globocan (IARC) 2008, 
WHO 2008, Jemal 2011). Colorectal cancer (CRC) is one f the most common cancers 
and the leading cause of death in the U.S. since the la e 1990s. The incidence of 
colorectal cancer was 51.8 per 100,000 of the U.S. population in 1999 and the age-
adjusted 2009 rate decreased to 44.7 per 100,000 in 2 09. The death rate was 20.5 per 
100,000 in 1999 and age-adjsuited rate in 2009 was 16.9 per 100,000 (SEER 1990-2010). 
About 140,000 new cases and 55,000 deaths occur each y r in the US (Wingo et al 
1995). Although the incidence rate and death rate are decreasing, CRC has remained a 
leading cancer on both incidence and deaths in the past two decades (USCS, CDC). The 
incidence rate of CRC rose between 1975 and 1985, since then the incidence rate had 
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steadily reduced except for a non-significant plateau during 1995-1998. In 2008, 
the incidence rate of CRC for men was 50.98 per 100,000 people and 39.64 per 100,000 
people for women. The goal of Healthy People 2020 is to reduce CRC incidence to 38.6 
per 100,000 people by 2020 (NCI 2012). 
The significance of CRC is reflected both in the population affected and the 
rankings. Globally, in 2008, about 1.2 million new cases and 608,700 deaths occurred 
due to colorectal cancer (Globocan (IARC) 2008).  It was found to be most prevalent in 
Oceania, Europe, and North America (Globocan (IARC) 2008).  In 2010, an estimated 
142,570 new CRC cases, 9.32% of all cancer new cases occurred in the United States. An 
estimated 51,370 people (9% of all cancer deaths) died from colorectal cancer (Jemal 
2010, ACS 2010). The incidence and mortality rates of CRC rank as the 3rd most 
frequent for both sexes (Jemal 2010, ACS 2010). The overall cost of cancer as estimated 
by the National Institutes of Health was $263.8 billion, 9% for CRC amounts to about 
$23.74 billion. Among these costs, $9.25 billion is for health expenditure, $1.88 billion is 
for lost productivity due to illness, $12.61 billion is for lost productivity due to premature 
death (ACS 2010). 
The lifetime risk of an individual being diagnosed with CRC has been estimated 
to be 5.42% for invasive CRC, and 5.73% if in situ CRC is included (SEER 1975-2004). 
The lifetime risk of dying from CRC is 2.20% in the U.S. The overall 5-year survival rate 
is 64%. It is 89-90% in persons with localized diseas , 68-69% in persons with regional 
spread, and only 10-11% in those with distant metastase  (Ries et al 2007; SEER Cancer 
Statistics Review 1975-2004). Even though the risk of CRC diagnosis or death exists, the 
survival rate of CRC is relatively high when diagnosed early. Almost 90% of those with 
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early CRC diagnosis survive for 5 years. But it is predicated upon early detection. 
Furthermore CRC can be prevented. Reducing the colorectal cancer death rate is one of 
the objectives of Healthy People 2020, the target rat  being 14.5 deaths per 100,000. In 
2008, the worldwide age-standardized mortality was 8.2%, accounted for approximately 
0.6 million individuals, and the age-standardized incidence was17.2%, accounted for 1.24 
million persons (Globocan (IARC) 2008). 
2.2  Colorectal cancer prevention and the role of polyps 
While the role of hyperplastic polyps in colon cancer is debated, benign 
adenomatous polyps have been documented to be the precursor for most cases of colon 
cancer, and polyps increase with age (Correa et al 1977, Rickert et al 1979). Detecting 
and removing adenomatous polyps is effective in reducing the incidence and mortality of 
CRC. Within polyps the proportion of villous architec ure (showing rapid growth) is 
positively associated with the size of adenomatous polyps and, furthermore, the potential 
of having malignant characteristics (Rickert et al 1979). Evidence shows that 
adenomatous polyps smaller than 10mm in diameter are arely found to be cancer. The 
villous architecture component is more likely to be found in adenomatous polyps larger 
than 10mm (Enterline et al 1962, Morson 1974, Muto et al 1975, Spjut et al 1977). 
According to Surveillance Epidemiology and End Results 17 (SEER-17), which 
captures cancer data in 17 metropolitan/rural regions (San Francisco, Connecticut, Detroit, 
Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, Sn Jose-Monterey, Los Angeles, 
Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, 
Louisiana and New Jersey) 2002-2004, the lifetime risk of being diagnosed with CRC is 
lowest in American Indians/Alaskan Natives (4.27% for invasive CRC and 4.45% for 
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invasive and in-situ CRC), followed by Hispanics (4.82% for invasive CRC and 5.08% 
for invasive and in-situ CRC), and highest in Asian/Pacific Islanders (5.58% for invasive 
CRC and 5.83% for invasive and in-situ CRC). The lifetime risk of dying from CRC is 
lowest in American Indians/Alaskan Natives at 1.86%, followed by Hispanics at 1.92%, 
and is highest in Blacks at 2.42% (Ries et al 2007). The pattern of lifetime risks between 
ethnics of being diagnosed with CRC mirrors the pattern of lifetime risk of dying from 
CRC. 
Polyps in the colon are associated with different histology types. Some types of 
polyps are more likely to be found in the left colon while others were not. Hyperplastic 
polyps are most commonly found in the rectum – 86.1% of total polyps. Neoplastic 
adenomas are the second most common, and both increase with age and are more 
prevalent in men (Williams et al 1982). Although there is no consistent relationship 
between the size of adenomas and age, as age increases, adenomas larger than 1 cm in 
diameter are more prevalent. Sessile adenomas are more prevalent in the cecum, while 
pedunculated adenomas had an increasing prevalence in th  distal colon and were most 
prevalent in the sigmoid colon (Williams et al 1982) While the role of hyperplastic 
polyps in colon cancer is debated, benign adenomatous p lyps have been documented to 
be the precursor for most cases of colon cancer, and polyps increase with age (Correa et 
al 1977, Rickert et al 1979). Detecting and removing adenomatous polyps is effective in 
reducing the incidence and mortality of CRC. Within polyps the proportion of villous 
architecture (showing rapid growth) is positively associated with the size of adenomatous 
polyps and, furthermore, the potential of having malign nt characteristics (Rickert et al 
1979). Evidence shows that adenomatous polyps smaller than 10mm in diameter are 
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rarely found to be cancer. The villous architecture component is more likely to be found 
in adenomatous polyps larger than 10mm (Enterline et al 1962, Morson 1974, Muto et al 
1975, Spjut et al 1977). 
According to Surveillance Epidemiology and End Results 17 (SEER-17), which 
captures cancer data in 17 metropolitan/rural regions (San Francisco, Connecticut, Detroit, 
Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, Sn Jose-Monterey, Los Angeles, 
Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, 
Louisiana and New Jersey) 2002-2004, the lifetime risk of being diagnosed with CRC is 
lowest in American Indians/Alaskan Natives (4.27% for invasive CRC and 4.45% for 
invasive and in-situ CRC), followed by Hispanics (4.82% for invasive CRC and 5.08% 
for invasive and in-situ CRC), and highest in Asian/Pacific Islanders (5.58% for invasive 
CRC and 5.83% for invasive and in-situ CRC). The lifetime risk of dying from CRC is 
lowest in American Indians/Alaskan Natives at 1.86%, followed by Hispanics at 1.92%, 
and is highest in Blacks at 2.42% (Ries et al 2007). The pattern of lifetime risks between 
ethnics of being diagnosed with CRC mirrors the pattern of lifetime risk of dying from 
CRC. 
Polyps in the colon are associated with different histology types. Some types of 
polyps are more likely to be found in the left colon while others were not. Hyperplastic 
polyps are most commonly found in the rectum – 86.1% of total polyps. Neoplastic 
adenomas are the second most common, and both increase with age and are more 
prevalent in men (Williams et al 1982). Although there is no consistent relationship 
between the size of adenomas and age, as age increases, adenomas larger than 1 cm in 
diameter are more prevalent. Sessile adenomas are more prevalent in the cecum, while 
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pedunculated adenomas had an increasing prevalence in th  distal colon and were most 
prevalent in the sigmoid colon (Williams et al 1982) While the role of hyperplastic 
polyps in colon cancer is debated, benign adenomatous p lyps have been documented to 
be the precursor for most cases of colon cancer, and polyps increase with age (Correa et 
al 1977, Rickert et al 1979). Detecting and removing adenomatous polyps is effective in 
reducing the incidence and mortality of CRC. Within polyps the proportion of villous 
architecture (showing rapid growth) is positively associated with the size of adenomatous 
polyps and, furthermore, the potential of having malign nt characteristics (Rickert et al 
1979). Evidence shows that adenomatous polyps smaller than 10mm in diameter are 
rarely found to be cancer. The villous architecture component is more likely to be found 
in adenomatous polyps larger than 10mm (Enterline et al 1962, Morson 1974, Muto et al 
1975, Spjut et al 1977). 
According to Surveillance Epidemiology and End Results 17 (SEER-17), which 
captures cancer data in 17 metropolitan/rural regions (San Francisco, Connecticut, Detroit, 
Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, Sn Jose-Monterey, Los Angeles, 
Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, 
Louisiana and New Jersey) 2002-2004, the lifetime risk of being diagnosed with CRC is 
lowest in American Indians/Alaskan Natives (4.27% for invasive CRC and 4.45% for 
invasive and in-situ CRC), followed by Hispanics (4.82% for invasive CRC and 5.08% 
for invasive and in-situ CRC), and highest in Asian/Pacific Islanders (5.58% for invasive 
CRC and 5.83% for invasive and in-situ CRC). The lifetime risk of dying from CRC is 
lowest in American Indians/Alaskan Natives at 1.86%, followed by Hispanics at 1.92%, 
and is highest in Blacks at 2.42% (Ries et al 2007). The pattern of lifetime risks between 
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ethnics of being diagnosed with CRC mirrors the pattern of lifetime risk of dying from 
CRC. 
Polyps in the colon are associated with different histology types. Some types of 
polyps are more likely to be found in the left colon while others were not. Hyperplastic 
polyps are most commonly found in the rectum – 86.1% of total polyps. Neoplastic 
adenomas are the second most common, and both increase with age and are more 
prevalent in men (Williams et al 1982). Although there is no consistent relationship 
between the size of adenomas and age, as age increases, adenomas larger than 1 cm in 
diameter are more prevalent. Sessile adenomas are more prevalent in the cecum, while 
pedunculated adenomas had an increasing prevalence in th  distal colon and were most 
prevalent in the sigmoid colon (Williams et al 1982) While the role of hyperplastic 
polyps in colon cancer is debated, benign adenomatous p lyps have been documented to 
be the precursor for most cases of colon cancer, and polyps increase with age (Correa et 
al 1977, Rickert et al 1979). Detecting and removing adenomatous polyps is effective in 
reducing the incidence and mortality of CRC. Within polyps the proportion of villous 
architecture (showing rapid growth) is positively associated with the size of adenomatous 
polyps and, furthermore, the potential of having malign nt characteristics (Rickert et al 
1979). Evidence shows that adenomatous polyps smaller than 10mm in diameter are 
rarely found to be cancer. The villous architecture component is more likely to be found 
in adenomatous polyps larger than 10mm (Enterline et al 1962, Morson 1974, Muto et al 
1975, Spjut et al 1977). 
According to Surveillance Epidemiology and End Results 17 (SEER-17), which 
captures cancer data in 17 metropolitan/rural regions (San Francisco, Connecticut, Detroit, 
15 
 
Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, Sn Jose-Monterey, Los Angeles, 
Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, 
Louisiana and New Jersey) 2002-2004, the lifetime risk of being diagnosed with CRC is 
lowest in American Indians/Alaskan Natives (4.27% for invasive CRC and 4.45% for 
invasive and in-situ CRC), followed by Hispanics (4.82% for invasive CRC and 5.08% 
for invasive and in-situ CRC), and highest in Asian/Pacific Islanders (5.58% for invasive 
CRC and 5.83% for invasive and in-situ CRC). The lifetime risk of dying from CRC is 
lowest in American Indians/Alaskan Natives at 1.86%, followed by Hispanics at 1.92%, 
and is highest in Blacks at 2.42% (Ries et al 2007). The pattern of lifetime risks between 
ethnics of being diagnosed with CRC mirrors the pattern of lifetime risk of dying from 
CRC. 
Polyps in the colon are associated with different histology types. Some types of 
polyps are more likely to be found in the left colon while others were not. Hyperplastic 
polyps are most commonly found in the rectum – 86.1% of total polyps. Neoplastic 
adenomas are the second most common, and both increase with age and are more 
prevalent in men (Williams et al 1982). Although there is no consistent relationship 
between the size of adenomas and age, as age increases, adenomas larger than 1 cm in 
diameter are more prevalent. Sessile adenomas are more prevalent in the cecum, while 
pedunculated adenomas had an increasing prevalence in th  distal colon and were most 
prevalent in the sigmoid colon (Williams et al 1982).  
2.3  Identifying at-risk population 
2.3.1 Average-risk persons 
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Incidence and death rates of CRC increase with age. In the US population, the 
incidence rate exceeds 100 per 100,000 from the 60-64 age group, and the death rate 
accelerates from the 75-79 age group (SEER Cancer Statistics Review, 1975-2008). In 
South Carolina, the incidence rate of more than 10/100,000 is observed starting in the 55-
59 age group, and death rate exceeds 10/100,000 in the 75-79 age group for the mortality 
rate (SC SCAN). Figure 2.1 – Figure 2.4 show the incidence rate and the mortality rate of 




Cancer Incidence: Full (Research) File 
 
For South Carolina Residents 
County: All Counties in South Carolina 
Primary Cancer Sites: Colorectal (colon, rectum, and rectosigmoid) 
Age 
 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85+ 
Year Rates Rates Rates Rates Rates Rates Rates Rates Rates Rates Rates 
1996 10.5 19.1 36.1 69.6 100.7 156.2 190.8 275.5 316.5 366.7 429.6 
1997 10.7 17.6 39.2 62.4 109.3 161.5 187.3 280.2 334.4 320.3 437.9 
1998 13.8 18.2 38.7 64.4 110.6 161.9 214.0 302.2 344.0 418.1 402.5 
1999 9.2 18.5 35.8 72.9 108.2 154.2 233.0 279.1 342.2 336.2 407.0 
2000 8.6 21.8 45.6 65.2 108.1 161.2 210.6 274.9 321.3 414.1 402.8 
2001 10.4 24.1 44.5 63.4 101.7 157.6 199.4 285.2 318.8 387.5 383.2 
2002 11.3 23.5 45.1 70.9 105.4 161.2 233.1 283.1 326.6 362.5 364.0 
2003 13.2 23.5 38.8 73.6 117.8 156.8 245.2 291.8 302.0 335.6 359.6 
2004 16.2 27.3 34.5 79.2 110.1 138.0 216.7 259.4 323.1 346.1 370.4 
2005 10.0 15.4 32.5 75.1 107.7 143.6 200.8 243.3 281.1 346.6 328.3 
2006 14.3 21.2 41.9 66.0 91.0 131.1 195.3 221.9 259.8 280.2 256.0 
2007 10.7 17.6 39.4 77.4 92.4 124.0 179.6 201.2 256.4 244.7 291.2 
2008 8.9 20.1 39.4 68.5 84.4 115.1 159.0 186.4 228.8 260.2 277.4 
2009 8.4 16.9 40.7 59.1 77.1 108.1 139.3 166.9 206.0 216.8 244.0 
*Rate: Crude Rate calculated per 100,000 population 
Figure 2-1 Colorectal cancer incidences in the pastdecade 
 
 









For South Carolina Residents 
County: All Counties in South Carolina 
Primary Cancer Sites: Colorectal (colon, rectum, and rectosigmoid) 
Age 
 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85+ 
Year Rates Rates Rates Rates Rates Rates Rates Rates Rates Rates Rates 
1996 # 6.6 10.9 14.5 34.2 42.9 66.4 106.8 108.8 182.4 270.9 
1997 # 5.1 12.0 18.9 33.2 40.7 63.8 91.2 123.0 157.6 246.7 
1998 # 5.3 8.0 19.2 30.6 37.8 58.1 87.0 124.9 178.0 230.3 
1999 # 6.8 10.3 21.4 30.1 49.6 67.6 80.4 123.1 166.5 252.8 
2000 # # 10.4 15.8 37.0 41.9 61.7 101.8 121.5 185.2 268.6 
2001 # 8.6 11.5 16.9 23.8 39.5 75.7 79.3 129.9 153.5 229.2 
2002 # 7.9 12.9 18.5 22.8 54.7 57.6 79.5 112.7 149.3 228.9 
2003 # 7.3 13.4 14.7 26.7 46.8 57.5 84.4 102.6 161.6 222.7 
2004 # 6.3 6.8 18.2 27.8 32.6 51.8 67.0 106.1 136.4 194.9 
2005 # 5.7 12.7 15.1 26.1 37.5 59.2 60.6 106.5 145.3 231.0 
2006 # 4.7 10.0 17.1 30.8 45.1 65.9 74.0 102.1 134.0 158.9 
2007 # # 8.7 13.7 25.3 44.3 50.7 67.8 113.4 84.4 172.4 
2008 # 5.5 11.7 18.2 24.6 27.9 49.6 78.1 82.4 110.2 195.0 
2009 # # 10.9 17.9 26.2 35.4 40.4 58.8 81.0 118.3 167.0 
*Rate: Crude Rate calculated per 100,000 population 
Figure 2-3 Colorectal cancer mortalities in the past decade 
 
 
Figure 2-4 The trend line of colorectal cancer mortality in the past decade
 
The U.S. Preventive Services Task Force (USPSTF), the American Cancer 
Society (ACS), the National Comprehensive Cancer Network (NCCN), and the U.S. 
Multi-Society Task Force (MSTF) recommend periodic screenings of the average
population to prevent CRC, which includes men and women aged over 50 years with no 
history of adenomas, colorectal cancer, inflammatory b wel disease, and family history 
(USPSTF 2008, Levin 2008, NCCN 2012). The USPSTF recommends routine CRC 
screenings with fecal occult blood test (FOBT), sigmoidoscopy, or colonoscopy for 
adults aged 50-75 years. Between 76 and 85 years old, routine screening is not 
recommended, but it can be provided a
considerations. For patients older than 85 years, CRC screening is not recommended 
(USPSTF, 2008).  
2.3.2 High-risk persons 
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Asymptomatic individuals with a family history are categorized as high-risk for 
colorectal cancers. This group of persons is recommended to have screening at an earlier 
age than the average-risk group. The American College of Gastroenterology (ACG), the 
ACS and the NCCN have updated standards of the high-risk population and the 
recommended screening guidelines (Levin 2008, Rex 2009, NCCN 2012): 
Persons with single first-degree relative with CRC or advanced adenoma 
diagnosed at age < 60 years or two first-degree relatives with colorectal cancer 
or advanced adenomas will be considered as high risk population, and are 
recommended to have colonoscopy screening every 5 years beginning at the age 
of 40 years, or 10 years younger than the age at diagnosis of the youngest 
affected relative. Or, with personal history of adenoma/sessile serrated polyps, 
colon cancer, or inflammatory bowel disease (i.e., ulcerative colitis, Crohn’s 
disease) additional screenings are recommended.  
Other persons defined as high-risk have one of two hereditary syndromes (Byers 1997): 
• Familial Adenomatous Polyposis syndromes (FAP) 
People with this condition develop hundreds of colorectal polyps and will almost 
certainly develop colorectal cancer unless the colon is removed. 
• Hereditary Non-Polyposis Colorectal Cancer syndromes (HNPCC) 
HNPCC has been classically defined as colorectal cancer in three or more family 
members, two of whom are first-degree relatives of the third, involving people in at 
least two generations, and with at least one person diagnosed with colorectal cancer 
before age 50 years. 
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HNPCC, also known as the Lynch syndrome, accounts for approximately 5% of 
new cases of CRC each year (Winawar 1997). 
Persons with a family history of hereditary syndromes, with relatives who 
received diagnoses of colorectal cancers at an early age, with two or more affected 
relatives, or with persistent ulcerative colitis have a high risk of colon cancers. The risk is 
especially high among younger persons (40-59 years old), but not associated with 
individuals after 60 (Fuchs et al 1994). Other principal risk factors include a history of 
colorectal cancers or adenomas in a first-degree relativ , a personal history of large 
adenomatous polyps or colorectal cancers, and a prior diagnosis of endometrial, ovarian, 
or breast cancers (Rustogi 1994, USPSTF (Baltimore), 1996). Based on an ACS report in 
1981, the high-risk population was described as (Eddy, 1981): 
“Persons with familial polyposis, Gardner’s syndrome, ulcerative colitis, a 
history of polyps or prior colon cancer, and a family history of cancer of the 
colon or rectum”. 
2.4  Early CRC detection and management 
CRC is highly curable if detected in an early stage through routine screenings of 
the colon/rectum. When polyps/adenomas are detected and removed in the early 
developmental course, the 5-year relative survival rate is 90% (CDC 2011).  
Among the screening methods, the effectiveness of the screening tool for 
detecting neoplasia lesions is critical. Theoretically, sensitivity is defined as the ability of 
the tool to identify true positives among all positives. In case of CRC, sensitivity is the 
percentage of people who have neoplastic lesions who are correctly identified by the 
screening tool as having the condition. Sensitivity is highest for colonoscopy, followed 
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by flexible sigmoidoscopy, followed by fecal tests, Hemoccult SENSA being the best 
followed by fecal immunochemical test, and lowest for Hemoccult II (USPSTF 2008). 
Specificity of the screening tool is defined as the ability to identify true negatives among 
all negatives. In case of CRC, specificity is the percentage of people with no neoplastic 
lesions who are correctly identified as clear. Specificity is highest for colonoscopy as 
well, followed by flexible sigmoidoscopy, then Hemoccult II, which is also 
approximately equal to fecal immunochemical test, and lowest for Hemoccult SENSA 
(USPSTF 2008). 
One randomized clinical trial study in 1993 exploring the effect of FOBT 
screenings on CRC mortality for up to 13 years of follow-up reported that the annual 
FOBT group had the highest 13-year survival rate, with a 33% reduced mortality from 
colon cancers compared to the control group, and almost double the reduction observed 
in the biennial FOBT group (Mandel et al 1993). Although observational studies have 
reported incidence/mortality reductions associated with screening colonoscopy and 
polypectomy (Winawar et al 1993, Zauber et al 2012), less than half of the US screening-
eligible population is covered by screening (Meissner et al 2006, Seeff et al 2004). 
Research has shown the effect of early detection and the removal of precancerous lesions 
through screening on CRC incidence and mortality reduction in the United States 
(Edwards et al 2010, Center et al 2009, Chu et al 1994). 
Less than 40% of colorectal cancers are detected at an early stage (CDC 2011). 
According to the National Health Interview Survey (NHIS) in 2005, only 50% of U.S. 
people aged 50 to 75 years had received a colorectal cancer screening. Colorectal cancer 
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screening take up rate remains low and there is still a b g gap to fill given that the target 
rate in the Healthy People 2020 is 70.5%. 
Except for patients with bowel symptoms, the physician recommendation/referral 
is a required precondition for CRC screenings. Although Medicare coverage of 
colonoscopies since 2001 reduced the racial disparity in colonoscopy screenings between 
older Whites and Blacks (Shih et al 2006), studies suggest that physician 
recommendations are less frequent for Blacks  than for Whites both in the general 
population, and among Medicare beneficiaries (Klabunde et al 2006), which translates to 
a lower screening rate among Blacks. The low take up rate and the disparity in the access 
of screening could be a potential reason for Blacks having a relatively high CRC 
incidence (Rex 2004, Daguise et al 2006). 
2.5  History of CRC screening in the US 
Before 1980, the American Cancer Society (ACS) recommended that people aged 
over 40 years should be screened with the annual sigmoidoscopy. The digital proctoscope 
and occult blood examinations were urged to be included in the regular health checkups 
for adults over age 40 by the ACS (Eddy 1980). Based on an ACS report in 1981, those at 
high risk were recommended to have more “f quent” and “intensive” examinations 
starting at an earlier age (Eddy, 1981). In a June 1992 meeting, revisions were made by 
the National Board of Directors of the American Cancer Society to the guidelines for 
asymptomatic individuals (Levin et al 1992): 
1. Sigmoidoscopy, preferably flexible, for persons aged 50 and older, males and 
females, every three to five years. 
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2. “Fecal Occult Blood Test (FOBT)” substituted for “stool guaiac slide test” every 
year for individuals age 50 and over. 
The ACS also made a revision to recommendations for the high-risk population at 
this meeting in June 1992 (Table 2-1) (Levin & Murphy 1992): 
1. If first-degree relatives have a CRC diagnosis at an age less than 55 years, a 
colonoscopy or a double-contrast barium enema (DCBE) was recommended every 5 
years starting at age 35 – 40 years. 
2. If family members have a history of familial adenomatous polyposis, early flexible 
sigmoidoscopy is required. 
3. If family members have a history of hereditary nonply osis CRC, early initiation 




Table 2-1 American Cancer Society Recommendations fr the Early Detection of Colon 
Cancer in Asymptomatic Persons (1992) 
Test or Procedure Population 
Sex Age Frequency 
Sigmoidoscopy, Perferably Flexible Male & Female 50 and over Every 3 to 5 years 
Fecal Occult Blood Test Male & Female 50 and over Every year 
Digital Rectal Examination Male & Female 40 and over Every year 
Source: Levin B, Murphy GP. Revision in American Cancer Society Recommendations for the 
Early Detection of Colorectal Cancer. CA Cancer J Clin. 1992; 42(5): 296-9. 
Although FOBT alone is shown to have a significant effect on CRC mortality 
reduction (Mandel 1993), the 1997 ACS Clinical guidelines (Table 2-2) had an additional 
recommendation of “sigmoidoscopy screening every 5 years to complement the annual 
FOBT” (Byers 1997), due to later findings from RCT studies that about one third to one 
half of mortality reduction observed from FOBT may be attributed to colonoscopies 
(Lang 1994), and to substantial risk reduction conferred by sigmoidoscopies (Selby 1992, 
Newcomb 1992). The ACS recommends sigmoidoscopy screenings every 5 years in 




Table 2-2 The 1997 ACS colorectal screening guidelines (Byers 1997) 
Average risk people 
(Single first-degree relative 
diagnosed with CRC, or 
adenomas after age 50, or no first-
degree relative, or those without 
any personal or family history of 
CRC or adenomas) 
Screening by either one of methods: 
1. Annual FOBT with sigmoidoscopy every 5 
years. 
2. Annual FOBT with colonoscopy every 10 
years. 
3. Annual FOBT with DCBE every 5 to 10 
years. 
Moderate risk people 
(People who are diagnosed as 
having adenomatous polyps) 
1. Remove adenomatous polyp at the procedure, 
followed by surveillance in 3 years. 
2. If the original polyp was smaller than 
1cm/non-villous pathology and the 3-year 
surveillance is negative, then back to average 
risk pool. 
3. If the original polyp was larger than 1cm or 
villous pathology, the surveillance should be 
repeated every 5 years. 
High risk people 1. If FAP confirmed, consider colectomy. 
2. If HNPCC confirmed, colonoscopy every 2 
years until age 40, every year thereafter. 
In 1996, the USPSTF first published the guidelines for colorectal cancer 
screenings with these screenings were fecal occult-blood tests or sigmoidoscopies 
(USPSTF (AHRQ), 1996). Two years later, these screenings were covered by Medicare 
(http://healthservices.cancer.gov/seermedicare/considerations/testing.html); in 2000, most 
health plans covered at least one of four recommended colorectal cancer screening tests 
(Klabunde et al 2004). Medicare covered colonoscopies starting from 2001 (Shih 2006). 
In 2002, the USPSTF found strong evidence on the effectiveness of several screening 
methods in reducing mortality, such as 5-year sigmodoscopy alone or in combination 
with the FOBT. However, the evidence that colonoscopies reduce mortality was still 
insufficient. The USPSTF also concluded that evidence was insufficient to assess the 
benefits and harms of computed tomographic colonography and fecal DNA testing as 
screening modalities for colorectal cancer (USPSTF 2002). In 2008, the USPSTF updated 
the recommendations for CRC screenings, recommending an ual FOBT, 5-year 
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sigmoidoscopy, or colonoscopy, beginning at age 50 years and continuing until age 75 
years (USPSTF 2008). In contrast to the 2002 USPSTF recommendation statements, the 
USPSTF updated the recommended screening eligibility from “individuals age 50 years 
and older” to “50 years and continuing to 75 years.” Also, high-sensitivity FOBTs, 
sigmoidoscopies with interval FOBTs, or colonoscopies were recommended replacing the 
un-prioritized recommendations in 2002. For CT colongraphy and fecal DNA, the 
USPSTF concluded to maintain that there is insufficient evidence for recommendation 
(USPSTF 2008). 
2.6  CRC screening methods 
Screening tests for CRC prevention basically are cat gorized into 2 types, the 
fecal tests (such as the Fecal Occult Blood Test (FOBT)), and the full or partial structure 
tests, such as Digital Rectal Examination (DRE), sigmoidoscopy, barium enema, 
Computed Tomographic (CT) colonography, and colonoscopy.  
There is insufficient evidence to determine which of these screening methods is 
preferable, or whether the combination of FOBT and sigmoidoscopy produces greater 
benefits than either test alone. Furthermore, there is insufficient evidence to recommend 
for or against routine screenings with digital rectal examinations, barium enemas, or 
colonoscopies, although recommendations against thee screenings in average-risk 
persons may be made on other grounds (USPSTF (Baltimore) 1996). The USPSTF 
recommended 3 screening methods: 1) annual high-sensitivity fecal occult blood testing, 
2) sigmoidoscopy every 5 years combined with a high-sensitivity fecal occult blood test 
every 3 years, and 3) screening colonoscopy at intervals of 10 years. Adherence to any of 
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the 3 methods is considered effective in detecting advanced adenomatous polyps and 
cancers at an early stage (USPSTF 2008). 
The three CRC screening methods commonly used are – fecal occult blood test 
(FOBT), flexible sigmoidoscopy, and colonoscopy. All tests lead to colonoscopies if they 
are positive, which permits the visual detection of early stage cancers and removal of 
adenomatous polyps simultaneously during the procedure (Denis et al 2011). 
2.6.1 Fecal occult blood test (FOBT) / Stool blood test 
Stool blood tests are broadly known as guaiac fecal o cult blood test (gFOBT) 
because the tests are designed to detect the occult blood in stool through guaiac method. 
CRC can be detected by finding occult blood in the stool, which is not readily visible. 
Also, the bleeding caused by cancers or advanced adnomatous polyps depends on the 
lesion size, friability, and location, and blood may might not be detected by the naked 
eye. But the problem with the stool blood test is is accuracy, because blood is unevenly 
distributed in the stool and the bleeding is intermittent. Further there are substances other 
than hemoglobin that can produce false positive results, such as iron in the diet (Eddy 
1981). CRC screening cannot rely solely on FOBT results, but can use FOBT results as a 
preliminary test. 
Besides false negatives caused by intermittent bleeding, faulty FOBT tests caused 
by diet should be avoided. Therefore, individuals are advised certain dietary limitations 
for two days before the stool blood test to avoid false positive results (most commonly 
caused by iron supplements and red meat) and false negative results (Vitamin C and 
citrus fruits) (Eddy 1981, Jaffe et al 1975, Garrick et al 1977).  
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Positive reactions on guaiac-impregnated cards, the most common form of testing, 
signal the presence of bleeding from premalignant adenomas and early-stage colorectal 
cancers (USPSTF (Baltimore) 1996).The stool blood test is far less likely to help prevent 
cancers compared to invasive tests such as flexible sigmoidoscopy or colonoscopy. To be 
effective, FOBT must be repeated at a regular interval, otherwise the protection is nil. 
When the test is positive, an invasive test, such as a colonoscopy, is needed (Levin et al 
2008). If patients are not willing to repeat the FOBT or take the invasive test when the 
FOBT is abnormal, FOBT is ineffective and should not be recommended (Levin et al 
2008). FOBT has very low test sensitivity (especially  single test) for detecting 
adenomas, and has a reasonable sensitivity for detecting colorectal cancers. However, 
regarding the program sensitivity (serial tests over time in a program), it is relatively 
high. Therefore, repeating testing each year is a very important key for ensuring the 
quality of FOBT (Levin et al 2008). In a randomized clinical trial of FOBT screening 
with a 13-year follow-up period, the results showed 33% reduction in colorectal cancer 
mortality, and better 5-year survival for those with annual FOBT screening (Mandel et al 
1993). 
Hemoccult, is the trademark for a guaiac reagent strip test for occult blood. 
Before the development of the Hemoccult, several chemical tests were used for blood 
stool test. These procedures require patients to have several samples of stool in cups or 
jars, which stand in the refrigerator for a couple days, which then have to be physically 
transported to the physician’s office or the hospital. I  is unpleasant for patients and for 
medical professionals who open the sample by the tim of examination. Another problem 
for the guaiac fecal occult blood test is that guaiac is very sensitive to heat and light. 
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Due to the issue of intermittent bleeding of polyps and cancers, Hemoccult II 
Slides are designed so that patients can collect serial pecimens at home from bowel 
movements over three days. This increases the probability of detecting hidden blood from 
polyps and cancer. After the patient prepares the Hemoccult II SENSA elite test, it may 
be returned in person or by mail to the laboratory, hospital or medical office for testing 
and interpretation. The test consists of two main components: 1) the test cards containing 
guaiac paper, 2) The Developer, a developing solution containing a stabilized mixture of 
less than 4.2% hydrogen peroxide and 80% denatured ethyl alcohol and enhancer in an 
aqueous solution. Research has shown that the rehydrated Hemocuult II slides show a 
high sensitivity in detecting CRC (92.2%) but disappointingly low specificity (90.4%), 
which causes too many colonoscopy referrals and prouces high corresponding costs 
(Byers 1997, Mandel 1993).  
A relatively new method for the fecal test is the fecal immunochemical test (FIT). 
FITs are highly specific in detecting human blood an  in eliminating the dietary 
restrictions. Research on the sensitivity and specificity of detecting the advanced 
adenomas, however, is disappointing. Allison’s (2007) study of three Northern Kaiser 
Permanente Medical Centers between April 1997 and October 1999 revealed that the 
sensitivity and specificity for advanced neoplasms in the left colon were only followed by 
colonoscopies within 2 years after the FOBT screening (29.5% for sensitivity and 97.3% 
for specificity). 
2.6.2 Digital rectal examination (DRE) 
The digital rectal examination is of limited value as a screening test for colorectal 
cancer. The examining finger, which is only 7-8 cm long, has limited access even to the 
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rectal mucosa, which is 11cm in length, where about one-sixth of the colon cancers occur 
(Eddy 1981, USPSTF (Baltimore) 1996).  
A digital (finger) rectal examination is used to che k for problems with organs or 
other structures in the pelvis and the lower belly. During the examination, the doctor 
gently puts a lubricated, gloved finger of one hand into the rectum. The doctor may use 
the other hand to press on the lower belly or pelvic area (Healthwise 2010). The results 
for DRE can be normal, where there are no problems such as organ enlargements or 
growths are felt, and vice versa. Growths such as hemorrhoids, polyps, tumors, or 
abscesses may be found in the lower rectum. Breaks in the skin around the anus (anal 
fissures) may be found; problems of the bladder mayalso be felt (Healthwise 2010). The 
DRE alone is not effective to check for colorectal ncers. If problems are found during a 
DRE, more advanced tests are needed, such as a sigmoidoscopy or a colonoscopy 
(Healthwise 2010).  
There are no formal studies/reports for the effectiv ness of DRE since the costs 
are small and its high safety feature, any benefits can be considered as worthwhile, the 
only potential harm is it might produce a false-positive results leading to other structure 
tests, such as sigmoidoscopies (Eddy 1980). Also, the DRE is not as effective as 
sigmoidoscopy because neoplasms can be hidden by mucus or any residual substances 
even within the area reached by exploring fingers (Eddy 1981). 
2.6.3 Sigmoidoscopy 
The sensitivity and the diagnostic yield of sigmoidoscopy screening varies with 
the type of instrument: the rigid (25cm) sigmoidoscope, the short (35cm) flexible 
sigmoidoscope, and the long (60cm) flexible fiberoptic sigmoidoscope (USPSTF 
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(Baltimore) 1996). The effectiveness of risk reduction for sigmoidoscopy has been 
widely documented (Lang 1994, Selby 1992, Mewcomb 1992). 
i. Rigid sigmoidoscopy 
The 25-cm rigid sigmoidoscopy was introduced in the 19th century but no longer 
used since 1982 (Eddy 1980, Mandel et al 1993). Theoretically, it can cover up to 25 cm 
of the colon, where about one-half to two-thirds of cancers and adenomatous polyps grow 
(Eddy 1981). There are pros and cons of rigid sigmodoscopes. It allows direct 
visualization of the colon, biopsy, and removal of the suspicious lesions. Patient 
discomfort and the risk of perforation of the colon are problems to be considered, 
however (Eddy 1981). Due to patient discomfort and the development of new technology, 
the rigid sigmoidoscopy is no longer used. A retrospective study in 1992 on the 
effectiveness of rigid sigmoidoscopy showed that par icipants who had undergone one or 
more rigid sigmoidoscopy examinations within the past 10 years had only 30% of the risk 
of dying from distal colon or rectum cancers relative to those who did not (Selby 1992). 
ii.  Flexible sigmoidoscopy 
The 35-cm flexible sigmoidoscope can visualize about 50-75% of the sigmoid 
colon and can detect about 50-55% of polyps (USPSTF (Baltimore) 1996). The 65-cm 
flexible fiberoptic sigmoidoscope enables a longer range visualization of the colon, 
however, the high cost and limited screening-only usage impedes its coverage in the 
United States (Eddy 1981). Men had a higher uptake r te of sigmoidoscopy than women 
(Meissner et al 2006). The detection rate of advanced neoplasia with sigmoidoscopy was 
three times higher than FOBT in an Italian randomized controlled trial (RCT) study 
(Segnan et al 2005). A randomized trial in the United Kingdom shows that a one-time 
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flexible sigmoidoscopy of adults aged 55-64 years reduced the incidence of colorectal 
cancer by 33%, and mortality by 43% (Atkin et al 2010).  
Sigmoidoscopies can also produce false-positive results, primarily from polyps 
detected that are unlikely to become malignant during the patients’ lifetime (USPSTF 
(Baltimore) 1996). It turns out that the majority of asymptomatic persons with colonic 
polyps discovered by routine sigmoidoscopic examinatio s will not develop into 
clinically significant malignancies during their lifetime. For these patients, interventions 
typically followed (i.e., biopsies, polypectomies, and frequent colonoscopies). Costly 
procedures, anxiety provoking, and potential harms are unlikely to make up for the 
clinical benefits of sigmoidoscopies (USPSTF(Baltimore), 1996). Flexible 
sigmoidoscopy was considered too expensive and specializ d only for early detection 
usage (Eddy 1980). 
Another disadvantage of sigmoidoscopy is the distribu ion of cancers in the colon. 
Studies indicated that the proximal colon cancer accounts for a significant portion of the 
colorectal cancers. The contribution of incident colon cancer in the proximal colon 
beyond the examination zone of sigmoidscopy is about 27% to 45% (Dinning 1994, 
Castiglione 1995, Lemmel 1996). The ratio of proximal cancer to total CRC is 0.338 
among men and 0.421 among women (SEER CanQues 1973-2009). 
A study explored the sites of primary CRC diagnosis from nine cancer registries 
between 1978 and 1988. It concluded that older population (70 years and older) has the 
greatest risk of CRC, and most commonly in the right colon (Rabeneck 2003). Although 
the incidence of CRC has steadily declined since 1975 (NCI 2012) due to increasing 
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aging population (65 years and older), the proportion of the population at risk of CRC is 
expanding with aging of the US population (Rabeneck 2003). 
2.6.4 Barium enema 
Barium enema is one variant of X-ray examination, and is of two types, single 
contrast barium enema (SCBE) and double contrast barium enema (DCBE). 
Barium enema examinations have been shown to better identify most of the 
advanced, most likely incurable, carcinomas of the colon instead of the early, potentially 
curable carcinomas of the colon. Therefore, the routine use of barium enema 
examinations is not reliable and is recommended for iscontinuation in the diagnostic 
evaluation of carcinomas of the colon (Gilbertsen et al 1979). 
i. Double Contrast Barium Enema (DCBE) 
During this procedure, the physician inserts a tube into the rectum, fills in barium 
sulfate, and drains its out, leaving a thin layer of barium on the wall of colon, and then air 
is filled in to define the outline of the colon. Then X-ray images from various angles are 
taken to better view the whole colon and detect abnormal growths (Byers 1997). A 
positive result in DCBE should be followed by a colonoscopy or a sigmoidoscopy (Byers 
1997). 
ii.  Single Contrast Barium Enema (SCBE) 
The difference between SCBE and DCBE is that the former fills the barium in the 
colon to outline the colon for detecting abnormal growths. The procedure time for SCBE 
is shorter than DCBE. SCBE is mostly performed for specific medical reasons or for 
older people who may not be able to tolerate the more time-consuming and 
uncomfortable DCBE procedure (Byers 1997). 
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The performance of barium enema varies by section of col n, and highest in the 
straight portions – descending colon (93%), transverse colon (89%), and ascending colon 
(88%); followed by the askew portions – the splenic flexure (86%), the hepatic flexure 
and the sigmoid flexure (83%). It is lowest in the globular portions – the rectum (77%) 
and the cecum (75%). The average sensitivity for cancer is 83%. In addition, the DCBE 
has better sensitivity than SCBE, with 0.78 being odds ratio of missed cancers (Rex, 
Rahmani, Haseman 1997).  
Overall, barium enemas are less expensive than coloosc pies. But colonoscopies 
enable direct visualization of the colon and removal f the suspicious lesions directly for 
biopsy with a one-time procedure if the bowel prepad properly. Colonoscopies have a 
higher sensitivity and are least likely to miss cancers, with an odds ratio of 0.25 relative 
to barium enema (Byers 1997, Rex, Rahmani, Haseman, 1997). 
2.6.5 CT colonography 
CT colonography also known as “virtual colonoscopy” or “X-ray colonoscopy”, 
which is noninvasive and based on radio-imaging. Carbon dioxide gas is introduced into 
the rectum to inflate the colon, and computer tomography pictures of the colon are taken 
by a moving scanner. The pictures taken are integrat d using computer programs to 
create a two- or three-dimensional virtual viewing of the colon (Wilkins 2008; NDDIC 
2008). Nationally, according to a report using the National Health Interview Survey 
(NHIS) 2010, the use of CR colonography is extremely low (1.3%) (Shapiro 2010).  CT 
colonography shows high sensitivity and specificity for detecting large polyps (>10 mm) 
but low sensitivity for smaller polyps. Pickhard and colleagues (2003) studied 1,233 
asymptomatic individuals undergoing same-day CT colon graphy and colonoscopy using 
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the segment unblinded method, which declares the findings of each section of the colon 
after it is examined by colonoscopy. They reported a sensitivity of 93.8% and 96% 
specificity on polyps of 10 or more millimeters; however, when polyps more than 6 
millimeters were included the sensitivity reduced to 88.7%, and specificity to 79.6%. 
Macari and colleagues (2005) using 2-dimensional views also reported the sensitivity of 
CT colongraphy reduced significantly with polyp size (>10 mm: 100%, 6-9 mm: 52.9%, 
1-5 mm: 11.5%).  
Besides the effectiveness of CT colonography in idetifying a polyp, a study in 
2008 of 2,531 asymptomatic individuals from 15 facilities using per-patient analysis 
showed that the sensitivity for polyps of 10 millimeters was 90% and 86% for specificity, 
which is consistent with the previous literature. However, the positive predictive value of 
CT colonography is 23% (with a high negative predictive value of 99%), which means 
the accuracy of diagnosis is extremely low, and the ability of radiologists identifying 
even the large polyps (>10mm) is an issue (Johnson 2008).  
 Interpreting CT colongraphy in non-academic environments has little evidence 
and poor outcomes. Burlings et al. (2006) investigated the interpretation accuracy of 13 
radiologists from seven non-academic facilities in comparison with that of trained 
radiographic technicians and experienced academic rad ologists. They showed that the 
individual accuracy highly varies among 13 non-academic radiologists (range from 53% 
to 93%). In addition, there are significant differenc s between these groups: the mean 
accuracy is highest in experienced academic radiologists (88%), followed by non-
academic radiologists (75%), and lowest in trained radiographic technicians (56%). 
Because of the low sensitivity in small and/or diminut ve polyps, it is not a valuable 
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method for the prevention of CRC. Also, the use of CT colonography has not been 
recommended by USPSTF due to the insufficient evidence on its benefits and harms 
(USPSTF 2008).  
2.6.6 Colonoscopy 
Evidence has shown that the rate of colonoscopy screening is increasing 
concurrent with a decline in the uptake of other screening tests. In the 2005 National 
Health Interview Survey (NHIS) study, the colonoscopy take up rate exceeded FOBT and 
sigmoidoscopy (Meissner et al 2006). This study also concluded that a large proportion of 
the take-up rate increment since 2000 was due to the increase in colonoscopy. The 
American College of Gastroenterology (2000) recommendation that colonoscopy was the 
preferred colorectal cancer screening test for average- isk individuals could have been the 
reason for the large increase in colonoscopy rate (Rex 2000). 
Colonoscopy, which requires sedation and often involves the use of a hospital or 
surgery center suite, is more expensive than other scr ening tests and has a higher risk of 
sedation and procedural complications (USPSTF (Baltimore 1996)). Retrospective 
studies have reported the effectiveness of colonoscopy is superior to sigmoidoscopy 
because approximately 60% to 70% of proximal cancers are not accompanied by 
neoplasms in the distal colon, which is the examinatio  zone of sigmiodoscopy (Dinning 
1994, Castiglione 1995, Lemmel 1996). Therefore a large proportion of test-negatives 
with sigmoidoscopy are not CRC-free. Proximal cancers account for 40% of the colon 




Research has shown that individuals with any distal adenomatous polyps were 
more likely to have advanced proximal neoplasia, the risk of advanced proximal 
neoplasia is significantly enhanced by increasing severity of distal adenomatous polyps 
(compared to patients without distal polyps). The relative risk of harboring distal 
hyperplastic polyps, distal tubular adenomas, and advanced distal polyps were 2.6, 4.0, 
and 6.7, respectively. Colonoscopy is irreplaceable mong individuals without any distal 
adenomas, because 2.7% had advanced proximal neoplasias (Lieberman 2000; Imperial 
2000). 
The effectiveness of colonoscopy in reducing CRC incidence and mortality 
depends on how thoroughly visualization of the entir  colon is achieved, the diligence in 
examining the mucosa, and patient acceptance of the procedure (Denis et al 2011). 
Colonoscopy has an advantage over barium enemas becuse it can be both diagnostic and 
therapeutic. Its advantage over flexible sigmoidoscopy is that it can access the entire 
colon while flexible sigmoidoscopy can only access the distal colon (Robertson et al 
2006). The use of colonoscopy in colorectal cancer s reening has increased concurrent 
with the decline in barium enema and flexible sigmoidoscopy (Robertson 2006; Klbunde 
2005). 
In conclusion, FOBT serves as the most cost-effectiv  in screening methods. 
Barium enema, although cheaper than colonoscopy, is not useful for therapeutic purpose. 
Sigmoidoscopy has similar features and is cheaper than colonoscopy. However, there is 
ample documentation of missed suspicious lesions beyond the examination range of 
sigmoidoscopy. Colonoscopy represents the most effective choice of screening method 
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because it enables both detection and removal of suspicious lesions in on step. Even with 
the price issue, screening with every 10 years makes it an attractive screening tool.  
2.7  Quality of colonoscopy / effectiveness 
Colonoscopy is currently regarded as the gold standard of colorectal cancer 
screening by removing polyps/adenomas (colonoscopic polypectomy) because there is 
strong evidence that polyps/adenomas are the precursor of colorectal cancer (Enterline et 
al 1967, Grinnell et al 1958, Kalus et al 1972, Muto e  al, 1975). The effectiveness of 
colonoscopy screening in preventing the development of colorectal cancer depends on the 
quality of examination. A successful colonoscopy can be identified by the rate of 
polyps/adenomas detected and the cecum intubated by the performer’s series of 
procedures. Achieving 95% cecal intubation rate is a recommended benchmark 
(USPSTF). Missed polyp/adenoma rates are documented at 6% to 27% depending on the 
size of polyps/adenomas (Hixson et al 1990, Rex et al 1997, Leaper et al 2004). Evidence 
regarding the effectiveness of colonoscopy has caused other screening methods to 
decline, and resulted in it being considered as the preferred method of CRC screening 
(Rex 2000, Rex 2009, Davila 2006, NCCN Clinical practice guidelines in oncology 
2011). 
With increasing use of colonoscopy, measuring colonoscopy quality is becoming 
inevitable to ensure its competent performance. Generally, the cecal intubation rate is the 
most commonly studied quality indicator, but is a very inadequate indicator. Poor quality 
colonoscopies limit its CRC protection potential.  
Adenoma detection, which has a documented association with CRC prevention 
and is the main goal of colonoscopy, should be a key indicator for studying colonoscopy 
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quality. A wide range of ADR among endoscopists has been documented (Millan 2008, 
Barclay 2006, Wilkins 2009, Rex 2001). This implies that the quality of colonoscopies 
varies widely, which could severely undermine its efficacy in CRC protection. Another 
major issue is the specialist capacity to meet the demand for colonoscopy screening if it 
becomes the primary screening method. Some studies have explored the effectiveness of 
colonoscopies performed by trained PCPs. 
A meta-analysis of 12 eligible studies of colonoscopies performed by PCPs with a 
total of 18,292 patients reported an adenoma detection rate of 28.9%. The authors 
concluded that the performance of PCPs can meet the prof ssional Societies’ 
recommended standards (Wilkins 2009). The associatin between colonoscope 
withdrawal time and adenoma detection rate was also studied, Barclay (2006) indicated 
that physicians who had a mean withdrawal time of less than 6 minutes (among patients 
with no polyp removed) had an overall adenoma detection rate of 11.8%, while it was 
28.3% for physicians whose mean withdrawal time wasmore than 6 minutes (without a 
polyp found). This statistically significant differnce persists in the mean number of 
adenomas detected per subject, which were 0.17 vs. 0.61, respectively. 
Rex et al (2001) videotaped 10 procedures performed by 2 colonoscopists and got 
them reviewed/scored by 4 experts based on four quality criteria related to colonoscopic 
withdrawal technique. They reported that technique do s matter to the adenoma miss rate, 
which could be further associated with the potential cancer protection efficacy of 
colonoscopy screening. Winawer et al (1993) conducted a prospective clinical trial of 
colonoscopy effectiveness (the National Polyp Study) over a mean follow-up of 5.92 
years, documented a CRC prevention rate of 76% following colonoscopic adenectomy. A 
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retrospective cohort study under an academic medical center setting reported a 100% of 
CRC protection over a mean follow-up of 5.34 years (Imperiale et al 2008). Zauber et al 
(2012) reported a 53% reduction in CRC mortality over a mean follow-up of 15.8 years 
per subject. 
Owing to its potential of a high level of CRC prevention, high-quality 
colonoscopy is recommended to be performed every 10 years for average risk population 
beginning at the age of 50 years, and 45 years for Blacks (Rex 2009). Colonoscopy every 
5 years at the age of 40 years, or 10 years before the arliest age of CRC diagnosis in a 
first-degree relative (high risk population) is recommended. 
2.7.1 Procedure quality indicators 
The National Comprehensive Cancer Network (NCCN) guidelines for CRC 
screening indicate that to evaluate the quality of colonoscopy, the following indicators 
should be considered (NCCN 2011): 
• Cecal intubation rate 
• Withdrawal time 
• Adenoma detection rate 
• Appropriate intervals between endoscopic examinatios based on family and 
personal history, and the number and histological type of polyps at last 
colonoscopy 
• Minor and major complication rates 
• Pre-procedure medical evaluations 
• Appropriate bowel preparation instructions 
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The cecal intubation rate and withdrawal time can be signal indicators for the 
quality of colonoscopy screening. Cecum intubation is set as the standard for a completed 
colonoscopy since the cecum is considered as the beginning of the large bowel. Reaching 
the cecum implies that the colonoscope was inserted all the way through the colon and 
rectum starting from the anus. In addition, withdrawal time (an average of 6 minutes or 
more when no polyps are removed) can be the surrogate for the percentage of colonic 
mucosa inspected (Barclay et al 2006, Rex 2006). 
i. Cecal intubation rate 
Three types of cecal intubation rates are defined, the unadjusted rate, the MSTF-
adjusted rate, and the circumstance-adjusted rate. The unadjusted rate measures the cecal 
intubation status for all study-eligible screenings. The MSTF-adjusted rate, according to 
the MSTF recommendations is calculated by excluding incomplete colonoscopies due to 
severe colitis or poor preparation (Rex 2002). The circumstance-adjusted rate further 
excludes procedures in which the endoscopist made a clinical decision not to attempt to 
reach the cecum because of severe diverticulosis, vital sign instability during the 
procedure, obstruction or stricture, or because it was a therapeutic procedure without the 
goal of cecal intubation, such as colon decompression, treatment of active lower 
gastrointestinal bleeding, removal of a previously discovered lesion, stent placement, 
etcetera (Aslinia 2006). The cecal intubation rate is the most commonly measured 
indicator and relatively easy to report as a preliminary quality indicator of colonoscopy 
(Aslinia 2006, Rex 2006, Rex 2002, Lieberman 2007). 
ii.  Procedure time 
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Colonoscope insertion time and withdrawal time are considered as appropriate 
quality indicators (Lieberman 2007, Rex 2009), especially when the ADR is low (Rex 
2006). Longer withdrawal time is shown to be associated with a better polyp detection 
rate (Rex 2000, Sanchez et al 2004). In contrast, shorter withdrawal time periods were 
associated with higher polyp miss rates (Rex 2000, Sanchez et al 2004). Also, the 
insertion time, which is the examination time period from insertion to the anus to the 
visualization of cecum, is documented to be associated with the adenoma detection rate 
(Benson et al 2005). In a series of 550 average-risk consecutive colonoscopy screenings 
performed by academic gastroenterologists, the ratio of nsertion time to withdrawal time 
was found to be positively related to the adenoma detection rate (Benson et al 2005). 
2.7.2 Outcome indicators 
i. Polyps 
A polyp is an overgrow tissue with part of its body attached to the site of origin. 
Studies suggest that about 1 in 4 colon cancers develop from polyps (Morson 1974, Muto 
et al 1975,Jass 1989), it takes averagely 10-15 years from a polyp to become a cancer by 
progression through the Stages of an adenoma (Morson 1974). Identifying and removing 
polyps during the screening exam has been considered the key to reduce the risk of 
developing colon cancers (Pabby 2005, Rex 2002, Rex 2006). When there are multiple 
polyps detected, they are most likely to be found in the ascending and transverse colon 
(Correa et al 1977). 
ii.  Adenomas 
The adenoma detection rate has lately attracted attntion as a key quality indicator 
because the main goal of colonoscopy is to search for and remove all adenomas to 
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prevent the CRC (Rex 2006, Lieberman 2007, Rex 2009). A positive correlation is 
documented between withdrawal time and adenoma detection rate (Barclay 2006, 
Barclay 2008, Millan 2008). Barclay et al (2006) study reported wide variation in the 
mean number of adenomas per subject, in the adenoma detection rate, and in the mean 
withdrawal time. With a mean withdrawal time more than 6 minutes, the physician’s 
detection rates of adenoma in their patient panels ar  higher than physicians with less 
than 6 minutes by around two and half folds (11.8% vs. 28.3%). The mean number of 
adenomas detected per subject for physicians with a mean withdrawal time more than 6 
minutes are nearly 4-fold larger than physicians with less than 6 minutes (0.17 vs. 0.61). 
In another study Barclay et al (2008) studied the association of a minimum of 8 minutes 
withdrawal time (mean for the endoscopist), and found that compared with endoscopists 
with a mean withdrawal time less than 8 minutes, those with at least 8 minutes have 
significantly higher rates of any neoplasia (37.8% vs 23.3%) and advanced neoplasms 
(6.6% vs 4.5%). More importantly, among the advanced n oplasms found by those with 
at least 8 minutes withdrawal time, 25% were 9 mm or less while for those with less than 
8 minutes, only 10% were 9 mm or less. This indicates that the more gradual inspection 
is, a higher number of smaller, potentially deadly neoplasms are found, some of which 
are missed otherwise.  
The adenoma detection rate shows a negative association with the risk of interval 
cancer. With a higher adenoma detection rate at colonoscopy, the hazard ratio of interval 
cancer for those physicians’ patients was reduced (Kaminski 2010). Compared with 
physicians having an ADR of more than 20%, the hazard ratio of interval cancer for 
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physicians with ADR less than 11% is 12.50, and about 11 for ADRs 11%-14.9% and 
15.0–19.9% (Kaminski 2010). 
2.8  Factors associated with CRC screening rates and adenoma rates 
2.8.1 Patient factors 
The factors associated with the uptake of CRC screening tests are widely 
documented, and are similar to other prevention screenings, including race/ethnicity, age, 
education, income, having health insurance coverage, and having a usual source of care. 
One study evaluated the 1987, 1992, 1998, 2000, and 2003 National Health Interview 
Survey (NHIS) findings (Meissner 2006). Use of CRC screenings was higher among 
individuals with private health insurance, a usual source of care, and who were older, 
White, married, having higher annual household income, and higher education (Meissner 
2006). The prevalence of adenomatous polyps was positively associated with age, but 
increasing age was not associated with an increase in polyp size (Rickert et al 1979, 
Hughes 1968). The incidence of colorectal cancer is higher in males than in females 
(Globocan (IARC) 2008, Jemal 2011, Meissner et al 2006). Nationally, the CRC 
incidence for Blacks is 12.3% higher than Whites (Rex et al 2004). In South Carolina, the 
disparity is worse; Blacks have approximately 30% higher incidence rates than Whites 
(Daguise et al 2006). Overall, men have a higher screening take up rate than women 
(Green et al 1999, Brawarsky et al 2003, Etzioni et al 2004). In 2000, women had a 
greater use of FOBT than men, but men had a higher endoscopy rate than women (Seeff 




The CRC death rate remains highest among Blacks (Gargiullo et al 2002). This 
may due to lower screening rates in this group (Thornton et al 2007; Zimmerman et all 
2006; James et al 2006; Vlahor et al 2005; Shokar et l 2007; Shokar et al 2008; Zhao et 
al 2006). At a population-level, reduction in CRC incidence rates are about 50% less 
among Blacks than among Whites (Gargiullo et al 2002). CRC incidence rates among 
Whites have been decreasing since 1985, and Blacks r te  have remained relatively 
unchanged (Gargiulo et al 2002; Jemal et al 2005; Ries et al 2000). Further, Blacks are at 
higher risk of being diagnosed at an advanced or metastatic stage, where Whites are more 
likely to be diagnosed at a non-advanced or localized stage (Weir et al 2003; Daguise et 
al 2006).  
Studies have demonstrated that Blacks suffered a higher proportion of adenomas 
in the proximal colon than Whites, which in other words, more proximal adenomas in 
Blacks that are missed by sigmoidoscopies (Thornton 2007, Johnson 1986, Ozick 1995, 
Mayberry 1995, Nelson 1997, Thomas 1992, Rex 2000). What makes worse is Blacks are 
documented to be less frequently screened by colonoscopy but sigmoidoscopy (Peterson 
2008).  
2.8.2 Physician factors in screening coverage 
Although the effectiveness of colonoscopy screening in preventing CRC is 
documented, screening colonoscopy coverage in the US population remains low. This is 
partly due to the low endoscopy capacity due to a shortage of providers. Currently, 
gastroenterologists are the main type of physician who performs screening colonoscopies. 
The capacity for screening colonoscopies by gastroen erologists shows a big gap between 
the supply of colonoscopies and the eligible population that needs to be screened. 
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According to the American Board of Internal Medicine, there are only 13,968 certified 
gastroenterologists in the US, annually increasing by460 gastroenterologists (ABIM 
2013). The colonoscopy capacity is only 63% (14.2 millions) of the estimated annual 
22.4 million colonoscopies (Seeff 2004), and the increase of the aging population, 
including baby boomers, widens the gap. To cover 100% of all age-eligible 
colonoscopies, an estimated additional 7,340 gastroen erologists are needed (Vijan 2004). 
In South Carolina, an estimated 484,000 colonoscopies are needed annually to screen the  
average-risk population older than 50 years; however, th  current colonoscopy capacity 
that could be provided if needed is 157,000, which shows an unmet need of two-thirds of 
screening colonoscopies, which stands in the way of realizing the CRC prevention 
benefits of colonoscopies (Seeff 2006). Similarly in Tennessee, the current estimated 
colonoscopy capacity based on gastroenterologists’ numbers alone is for 84,000 non-
Medicare insured patients per year to be provided screenings, whereas an estimated 
950,000 to 1.1 million additional screening colonoscopies are needed (Cattau 2010). An 
important point to consider is that when the supply of gastroenterologists is limited, 
especially in rural areas, colonoscopies provided by trained PCPs could be a solution to 
fill the gap. However, the widespread belief is that because gastroenterologists are 
specialists, they will have superior performance than non-gastroenterologists. One study 
showed that non-gastroenterologists detected colorectal cancer in 87% of patients with a 
true cancer compared to 97.3% of true cancer detected by gastroenterologists (Rex 1997). 
However, the distribution of incomplete colonoscopies among these groups was not 
reported, which may influence the interpretation of outcomes. Another factor noted by 
the author affecting the difference in cancer detection sensitivity of gastroenterologists 
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compared with non-gastroenterologists was the lack of information in the latters’ training 
in colonoscopy. Some of them were self-trained and others had variable (not 
documented) levels of colonoscopy training.  
Two Canadian studies reported that persons with colonoscopies performed by 
non-gastroenterologists had a higher risk of subsequent CRC compared to those 
performed by gastroenterologists. One retrospective ohort study of colonoscopies 
conducted in Canada during 1992-1997 with up to a 15-year follow-up of 110,000 
patients reported higher risks of interval cancer after a negative colonoscopy when 
patients were provided the service in a hospital setting by non-gastroenterologists 
compared to gastroenterologists (40% higher for general surgeons and 30% higher for 
internists and family physicians), but no differenc was found in physician office settings 
(Rabeneck 2010). Another study matched colonoscopies done in 1997-2002 with the 
Ontario Cancer Registry and also showed higher oddsf CRC for non-gastroenterologists 
compared with gastroenterologists among both men (OR=1.77) and women (OR=1.85) 
(Bressler 2007).  
In contrast, other research has shown that trained PCPs’ performance is 
comparable or better than the current benchmarks of quality set by the US MultiSociety 
Task Force (USMSTF) for gastroenterologists, from both the patient safety and adenoma 
detection perspectives (Wilkins 2009, Xirasagar 2009). Pierzchajlo (1997) reported a 
91.5% cecal intubation rate and 17.8% ADR among 751 colonoscopies performed by 
family physicians, which meets the USMSTF recommendation that ≥90% of 
colonoscopies should achieve cecal intubation consistently. This study’s ADR 
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approaches the ADR standards of ≥15% for women and ≥25% for men (Rex, Bond, 
Winawer 2002).  
Another series of 200 colonoscopies performed by family physicians documented 
highly competent performance by trained family physicians with 96.5% cecal intubation 
rate and 22.5% neoplastic polyp detection rate (Edwar s 2004). A retrospective case 
review of 731 colonoscopies performed by two family physicians credentialed for 
sigmoidoscopy and initially supervised by their refe ral gastroenterologist reported that 
they had a ADR of 27.2% in men and 21.4% in women, though the cecal intubation rate 
was close but lower than the USMSTF standard (89.5%) in their starting phase (1996-
1998) and improved to meet the USMSTF standard (94.6%) at a later phase (1999-2001) 
(Newman 2005).  
Another potential reason to consider PCPs for screening colonoscopies is that 
racially concordant PCPs may be more acceptable to black patients due to historic race 
relations and trust issues. Black patients have a higher incidence of CRC (about 16%) and 
47% higher CRC mortality than white patients. The ag of CRC onset is earlier among 
black patients, and CRC is more aggressive among younger age groups. Therefore it is 
important to increase screening colonoscopy rates among black patients. A previous 
study on the black PCPs trained in colonoscopy screening showed that they have a 
significantly positive impact on their black patients’ colonoscopy screening rates, 66% 
higher than those untrained in colonoscopy screening (9.4% before starting training vs. 
48.3% after the PCP started doing procedures). For black patients of trained PCPs, they 
are 5 times more likely to get a colonoscopy than white patients in the post training 
period; during the same period, their white patients’ colonoscopy screening rates remain 
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unchanged. In comparison, black patients of black untrained PCPs showed a change over 
the same period from 10.4% to 38.7%, and the white pa ients from13.3% to 13.2% 
(Xirasagar 2011). 
Comparing estimates of the number of gastroenterologists needed with the newly 
qualifying gastroenterologists each year, it will take approximately fifteen years to fill the 
colonoscopy capacity gap (Vijan 2004, ABIM 2013). Having primary care physicians 
perform screening colonoscopies may be a solution to cover the unscreened population, 
which is 60% of currently eligible population (Seeff 2004). However, the training of 
primary care physicians in colonoscopy remains very low. Only 4% of graduating family 
medicine residents applied for colonoscopy credentiali g in 2002 even though about half 
of the residency programs offered colonoscopy training to family medicine residents, and 
only 18% of these programs had anyone registering and getting trained (Wilkins 2004). 
While research has documented that “trained” primary c e physicians can provide 
competent and safe colonoscopy (Edwards 2004, Newman 2005, Wilkins 2009), there is 
no documentation of the training process or of the protocols used by high-performing 
PCPs. This study presents the protocol that was coniste tly used to train primary care 
physicians, which requires a 2-person technique, and includes other elements to 
maximize colon surface inspection and to minimize the likelihood of missing polyps. 
2.8.3 Procedure protocol features in colonoscopy quality – 2-person technique 
Physician fatigue is reported to be a likely factor in adenoma detection rates, 
particularly as the day progresses. Physicians’ ADRs for afternoon procedures were 
significantly lower than those of their own morning procedures (25.3% vs. 29.3%, 
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p=.008), with a 20% higher chance of detecting an adenoma in morning procedures 
relative to afternoon procedures (Sanaka 2009).  
The phenomenon of potentially lower quality output d e to fatigue is not limited 
to physicians. A study of the judicial system on the association between the likelihood of 
favorable parole ruling in the morning compared with the afternoon showed that judges 
were more likely to issue a favorable parole ruling i  the morning than in the afternoon 
and immediately after the lunch break than in the lat r afternoons. The authors suggested 
that mental fatigue level may be less at the beginning of the work day and after a short 
break to eat a meal or rest (Danziger 2011). In the cas  of colonoscopies, studies on the 
presence of second observers in colonoscopy procedures are shown to increase the 
colonoscopy quality in terms of adenomatous polyp detection. A retrospective study of 
the involvement of an attending gastroenterologist and a gastroenterology (GI) fellow 
reported that those procedures have significantly better ADR (37% vs. 23%, p<.01). 
Similarly the mean number of adenomas detected per subject (MNA) was higher (0.56 
vs. 0.3, p<.05), and the total number of adenomas detected among patients with 
adenomas was higher (procedures with 2 adenomas found was 13.1% vs. 5.6%, P<.05; 3 
and more adenomas found: 6% vs. 1.6%, p<.05) (Rogart 2008). These procedures had the 
trained GI fellow performing the procedure while th attending gastroenterologist was 
present in the room throughout watching the video screen and physically took over the 
scope for the difficult or complicated situations encountered, letting the fellow complete 
the remaining procedure after assistance was no longer needed. The procedure itself was 
performed by one person (either the fellow or the att nding gastroenterologist) at any 
given point. Another retrospective study that was not limited to screening colonoscopies 
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reported that the rate of small (<5mm) adenoma detection was significantly higher when 
a fellow performed the procedure and the attending gastroenterologist observed the 
screen, compared to the attending gastroenterologist performing the procedure without a 
GI fellow present (25%vs. 17%, p=.001) (Buchner 2011). The authors specified that more 
experienced fellows (e.g., the second-year and thir-year fellows) can perform the entire 
procedure with attending physicians’ oversight. 
A reduced likelihood of missing lesions due to visual fatigue is one advantage of 
having a 2-person technique where an additional person watches the video screen. In a 
recent prospective study, having a dedicated endoscopy nurse observe the screen while 
the attending physician performed the colonoscopy significantly increased the number of 
polyps detected per patient (adjusted OR=1.26) compared to the attending physician 
performing without a nurse observer. This effect was sustained for non-pedunculated 
polyps, showing that the nurse observer contributed to the detection of flat/sessile polyps 
(Aslanian 2013). 
Improvement in adenoma detection with a second participant in the procedure is 
further influenced by the experience level of the performer. Peters et al (2010) studied a 
similar protocol where fellows performed screening colonoscopies under the supervision 
of the attending physician. They compared these procedures with the GI attending 
physician performing alone. Similar to other studies, they reported that with a second 
practitioner involved in the procedure, tadenoma detection improved (odds ratio (OR) 
=1.32). Further, this improvement was correlated with the fellowship year of the GI 
fellow, the rate of adenoma detection for third-year f llows being almost double that of 
first year fellows (OR =1.7). In a prospective study in Korea, six hospitals followed a 
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protocol of having an endoscopy nurse administering the sedation under the 
endoscopist’s supervision and also serving as a second observer of the video screen for 
the colon inspection. As an observer, the endoscopy nurse assisted in identifying 
suspicious lesions through the screen, with no hands-o  assistance involved. With an 
endoscopy nurse as a second observer, the likelihood of finding a polyp/adenoma 
increased (OR =1.58 for polyp, and 1.47 for adenoma), an effect that was confined to 
fellows performing their 150th-500th procedures (OR =2.07) and this effect was not 
observed for senior attending gastroenterologists (Lee 2011). 
However, another non-randomized prospective study conducted at a single-center 
reported no significant difference in polyp detection rates with additional observers 
(single-person: 32%, dual-observers: 33%) and in adenoma detection (19.3% vs 14.9%) 
(Eckardt 2009). This study shared similar design elem nts as other studies: the trainee 
performs the procedure while the attending physician supervises and provides rescue 
assistance. The dual-person procedures showed a simil r PDR as the single person 
procedures, but showed a lower ADR because a higher proportion of diminutive (<5 mm) 
hyperplastic polyps were removed in the dual-person gr ups. 
To our knowledge, research on the “2-pearson technique” thus far has studied 
similar protocols, namely, having a second person as “observer”. In our study setting, the 
protocol uses a hands-on 2-person technique to compensate for the lack of specialist 
training of the PCPs. In this protocol, a trained en oscopy technician advances the 
colonoscope, and the PCP works the tip of the scope for polyp search and removal. This 
method has the additional advantage of avoiding missing polyps due to physician's motor 
fatigue particularly of the left or non-dominant hand. It confers the dexterity of two 
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“right” hands (of the two participants) for polyp search and removal, and further, ensures 
more persons watching the video screen for polyps. Additionally prior research on the 2-
person technique protocols involved a second observer with the polyp search limited to 
the phase of withdrawing the scope. Our study center requires gradual insertion and 
withdrawal of the colonoscope with polyp search andremoval both during insertion and 
withdrawal to maximize coverage of all mucosal surfaces and to minimize chances of 
“losing” a polyp that may be encountered during insertion but not traced during the 
withdrawal phase, which is the phase when gastroenterologists typically perform 
polypectomy. Because of these differences, the 2-person technique protocol in our study 
setting is unique and when applied to PCPs, the question arises, does this technique 
enable the quality of PCP-performed colonoscopies to be comparable to specialist-
performed colonoscopies. This study addresses this research question. 
2.8.4 Sedation during colonoscopy  
Colonoscopy can be painful and stressful to patients. The fear of discomfort may 
prevent some persons from accepting CRC screening. Concerns regarding unsedated 
colonoscopy may provide a negative perception of colonoscopy to the public, and hence, 
diminish the acceptability of colonoscopy, impeding the early detection of adenomatous 
lesions and thereby, limiting CRC protection (Rex & Khalfan 2005, Sipe, Rex , 
Latinovich 2002). Pain control is a priority for patients. Deep sedation puts patients into 
an unconscious state during the procedure and relieves patients of the anxiety of the 
impending discomfort. Deep sedation is therefore recommended, based on evidence that 
patients experienced little/no pain and that the endoscope is more readily advanced 
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through the colon when the patient is deeply sedated (R x & Khalfan 2005, Sipe, Rex, 
Latinovich 2002, Heuss 2004). 
Sedation for routine colonoscopy is either moderate or deep. Moderate sedation 
induces a state of drowsiness or sleep during most of the procedure, and is commonly 
performed with a benzodiazepine alone or with narcotics/opioids. Patients with moderate 
sedation can be readily awakened when spoken to or touched (American Society of 
Anesthesiologists (ASA). Deep sedation is a state wh re patients are asleep throughout 
the procedure with little or no memory, commonly induced with propofol. Patients with 
deep sedation breathe slowly, requiring oxygen at times, and sleep deeply until the 
medication wears off (ASA). 
Physical status is evaluated before sedating patients to assess fitness for the 
procedures as per the ASA Physical Status Classification System (Source: The Cleveland 
Clinic Foundation). This was developed in 1963 and is conventionally used: 
 ASA PS1: the normal healthy patient (no organic, physiologic, or psychiatric 
disturbance; excludes the very young and very old; healthy with good exercise 
tolerance) 
 ASA PS2: patients with mild systemic disease (no functional limitations; has 
well-controlled disease of one body system; controlled hypertension or 
diabetes without systemic effects, cigarette smoking without chronic 
obstructive pulmonary disease (COPD); mild obesity, pregnancy) 
 ASA PS3: patients with severe systemic disease (some functional limitations; 
has a controlled disease of more than one body system or one major system; no 
immediate danger of death; controlled congestive heart failure (CHF), stable 
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angina, old heart attack, poorly controlled hypertension, morbid obesity, 
chronic renal failure; bronchospastic disease with intermittent symptoms) 
 ASA PS4: patients with severe systemic disease that is a constant threat to life 
(has at least one severe disease that is poorly controlled or at the end-stage; 
possible risk of death; unstable angina, symptomatic COPD, symptomatic 
CHF, hepatorenal failure) 
 ASA PS5: moribund patients who are not expected to survive without the 
operation (not expected to survive > 24 hours withou  surgery; imminent risk 
of death; multiorgan failure, sepsis syndrome with hemodynamic instability, 
hypothermia, poorly controlled coagulopathy) 
 ASA PS6: a declared brain-dead patient whose organs c  be removed for 
donation purposes 
The efficacy of sedation is often assessed by the obs rver’s assessment of the 




Table 2-3 the observer’s assessment of the patient on the alertness/sedation scale 
Composite 
score 
Responsiveness Speech Facial 
Expression 
Eyes 
5 Responds readily to 
name spoken in 
normal tone 
Normal Normal Clear, no 
ptosis 
4 Lethargic response to 




Mild relaxation Glazed or mild 
ptosis (<1/2 
eye) 
3 Responds only after 

















1 Does not respond to 
mild 
prodding/shaking 
/ / / 
Source: Chernick DA, Gillings D, Laine H et al. Validity and reliability of the observer’s 
assessment of alertness/sedation scale: study with intravenous midazolam. J Clin 
Psychopharmacol 1990; 10: 244-51. 
2.8.5 Sedation type and colonoscopy quality 
There is little documentation of associations betwen sedation type and 
colonoscopy procedure quality and outcomes. The available evidence is mixed. Two 
major quality indicators, the procedure completion rate (cecal intubation), and adenoma 
detection rate show positive associations with deeper sedation in some studies (Chelazzi 
2009, Radaelli 2008, Wang 2010), and show no significant associations in other studies 
(Paspatis 2011, Rex 2012, Metwally 2011, Bannert 2012). 
Chelazzi et al (2009) reported that procedures carried out under propofol sedation 
have a 100% completion rate, while non-sedated procedures had only 91.1% completion 
rate (p<.05). The median insertion time was 9 minutes for the propofol group and 10.5 
minutes for the non-sedated group (p=.0086). In the same study, the total procedure time 
mirrored the insertion time pattern (15 min. vs. 19.5 min., p=.09). Because bowel 
preparation status significantly influences cecum intubation, Radaelli et al (2008) studied 
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the association between contribution of bowel preparation status, and sedation type. 
When compared to excellent bowel preparation, good bowel preparation is around 40% 
less likely to intubate the cecal (OR =0.586; poor: 0.246, inadequate: 0.013). Regarding 
sedation type, propofol-sedated procedures had the hig st odds of cecal intubation (OR 
=2.355), followed by the benzodiazepines and opiate regimen (OR =2.128), followed by 
the benzodiazepines alone (OR =1.46), compared to the no sedation group (OR =1). This 
study also explored the associations with polyp detection, and reported similar direction 
of associations to cecal intubation. The likelihood f etecting any polyp was highest in 
the propofol group (OR =1.317) compared to the non-sedated group, followed by 
benzodiazepines alone (OR =1.121), and there was no sig ificant difference between no 
sedation and the benzodiazepines and opiate group (OR=1.105, p>.05). 
A study from Greece using midazolam and pethidine sedation for all procedures, 
distinguished between moderate sedation (MS) and deep s dation (DS) based on dosage. 
They reported no significant difference in polyp detection rates (MS: 61.5%, DS: 63.6%), 
adenoma detection rates (MS: 59.5%, DS: 60.4%), and right colon polyp detection rates 
(MS: 34.4%, DS: 36.8%) (Paspatis 2011). Another study showed no difference between 
procedures sedated by propofol and by midazolam/fentanyl in adenoma detection rates 
(OR=1.07 (95%CI: 0.91, 1.26 for propofol)) (Metwally 2011). A retrospective cohort 
study across 72 facilities reported that with moderate sedation, the polyp detection rate 
was higher than deep sedation (37.7% vs. 34.1%, p<.0001). However, the advanced 
adenoma rate was higher for deep sedation (7.2% vs. 6%, p=.01), the effect being greater 
in facilities where deep sedation procedures exceeded 10% of its total procedures (7.5% 
vs. 5.7%, p=.003) (Wang 2010). 
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While evidence for procedure completion and detection of adenomatous polyps is 
mixed, sedation use has shown higher patient satisfac on on pain control. Propofol 
sedated patients were the most consistent in reporting no pain (102 out of 102 patients), 
while the midazolam group (17 out of 23 patients) and no sedation group (11 out of 22 
patients) had very low percentages indicating no pain (Gasparovic 2003). 
The duration over which the patient achieves adequat  sedation (onset time) and 
the duration in which the patient remains drowsy after the procedures (recovery time) 
remain important. When compared with moderate sedation, the deeply sedated group 
showed a shorter sedation onset time (time to sedate). Ulmer et al (2003) reported a mean 
sedation time of 2.1 minutes for propofol and 6.1 minutes for midazolam/fentanyl 
(p<.0001). For recovery time, studies have reported 7 to 16.5 minutes for propofol, 27.5 
minutes for midazolam/ fentanyl, 20 minutes for midazolam alone, and 33 minutes for 
midazolam/meperidine (Sipe 2002, Gasparovic 2003, Ulmer 2003). Deep sedation by 
propofol is significantly time saving as both procedure time and recovery time are 
shortened, compared to moderate sedation by any other sedative or combination of 
sedatives. However, the mixed results for the other quality indicators suggest the need for 
studies in settings where other protocol-related and procedure-related elements that 
influence these quality indicators are fixed, enabling unambiguous determinations of the 
sedative effect on these indications. A major limitation in comparing the various studies 
in sedation type vs. adenoma rate is the wide (undocumented) variation in all the other 
elements of the colonoscopy protocol and procedure tim s that would impact the ADR. 
Our study setting compared patients sedated with propofol (all procedures starting from 
April 2006) with midazolam-meperidine procedures pre-April 2006. 
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2.9  Significance of the research 
This research is based in a setting where all the remaining colonoscopy protocol 
elements other than the two study items were fixed throughout the study period. This 
allows the specific protocol elements (2-person technique or sedation type) to be 
accurately evaluated for their impact on ADR and other metrics of colonoscopy quality. 
An earlier study of 10,958 colonoscopies performed by 51 PCPs between October 
2002 and November 2007 in this setting documented th  high quality of screening 
colonoscopies performed by PCPs, all of whom were rqui ed to use the 2-person 
technique along with polyp-maximizing protocol. The quality indicators in that study 
cohort exceeded the ASGE-recommended standards of quality. The cecal intubation rate 
was 98.1%, which is higher than the ASGE standard of 95%. The adenoma detection rate 
was 30%, 34.6% in men and 25.4% in women, which are both above the ASGE standard 
(men ≥25%, women≥15%). The minimum withdrawal time recommended by the ASGE 
when no polyps are found is 6 minutes compared to the mean withdrawal time of 8 
minutes for no polyp procedures in a subset of the current study cohort (Xirasagar 2010). 
Other research has also documented that trained PCPs’ performance quality can meet the 
current benchmarks of quality established by the US MultiSociety Task Force on 
colonoscopies for gastroenterologists on both patient safety indicators and adenoma 
detection rates (Pierzchajlo 1997, Edwards 2004, Wilkins 2009, Newman 2005).  
It is possible that racially concordant PCPs may be more acceptable to black 
patients due to historic race relations and mistrust of black providers. A study of the 
patient panels of these PCPs showed high colonoscopy completion rates of 48.3% among 
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black patients of black PCPs trained in colonoscopy screening, showing a five-fold 
increase compared to before training rates (Xirasagr 2011).  
Literature regarding the relationship between propof l sedation and colonoscopy 
quality has focused largely on shorter onsets of sedation and shorter recovery times (Sipe 
2002, Gaspsarovic 2003, Ulmer 2003) and on better pain control (Gasparovic 2003) and 
procedure completion (Chelazzi 2009, Radaelli 2008). The evidence regarding propofol 
contribution to the detection of adenomatous polyps remains mixed, with no resolution in 
sight due to a lack of standardized procedure protocols across procedures with potential 
confounding.  
In short, the associations of the study center’s innovative hands-on 2-person 
technique with adenoma detection rates, and the associ tions of propofol sedation with 
clinical quality indicators need rigorous study. Additional indicators such as likelihood of 
finding smaller adenomas, and anatomic locations have not been studied so far. This 
study will test hypotheses regarding the associations of 2 protocol elements, 1) 2-person 
technique, and 2) propofol sedation, with adenoma detection rates, numbers of adenomas 
detected, procedure times, polyp sizes and polyp locati ns. The purpose is to further 
clarify whether these two protocol elements improve eff ctiveness in adenoma detection 
and therefore, effectiveness in preventing further colorectal cancer. 
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Chapter 3 METHODS  
This chapter discusses the methodology used in this s udy. Sample selection and 
statistical analysis methods used to achieve the study objectives will be displayed in this 
chapter. 
3.1  Research questions and Hypothesis 
An earlier study documented the high quality of screening colonoscopies 
performed by PCPs in this study setting without asses ing the role of the 2-person 
technique in the results (Xirasagar et al 2010). In that study a subset of the current series 
showed a cecal intubation rate of 98.1% , an adenoma detection rate of 30% (34.6% in 
men and 25.4% in women), and a mean colonoscope withdrawal time (when no polyps 
were found) of 8 minutes. The quality indicators in this study cohort exceed the ASGE-
recommended standard (Xirasagar 2010). Studies regardin  the 2-person technique have 
been limited to having a second observer in the procedure room (Rogart 2008, Buchner 
2011, Lee 2011). The 2-person technique element of the protocol in this study refers to 
having an endoscopy technician provide “hands-on” assistance to the endoscopist 
throughout the procedure in advancing and withdrawing the endoscope. In this study 
setting, all 54 PCPs who performed colonoscopies were required to use the 2-person 
technique. Among specialists/experts, 2 of them chose not to use the two-person 
technique. We studied the quality indicators in these three groups of procedures.  
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The documented literature regarding propofol sedation has focused on sedation 
onset and recovery time (Sipe 2002, Gasparovic 2003, Ulmer 2003), or better pain 
control (Gasparovic 2003) and procedure completion (Chelazzi 2009, Radaelli 2008), 
while the effect on detection of adenomatous polyps remains controversial.  
This study will address the following research question : 
1) Is the quality of colonoscopy performance by PCPs using a hands-on 2-person 
technique similar to that of specialists using a routine protocol (one person 
technique)? 
2) Within specialists, does the 2-person technique improve the adenoma yield and other 
indicators of better adenoma clearance?  
3) Does propofol sedation improve the quality of colonscopy performance outcomes? 
For all questions, we will study the indicators of adenoma detection rates, numbers 
of adenomas detected, procedure times, polyp sizes particularly small adenoma 
detections, and polyp anatomic locations. 
3.1.1 Research questions 
The literature and explanation documented in the previous chapters map out the 
research questions: 
1) Does the protocol element, 2-person technique, improve screening colonoscopy 
quality in terms of the adenoma detection rate, the number of adenomas, the size of 
polyp, and the location of polyp? 
2) Is sedation type associated with performance quality in erms of the adenoma 
detection rate, the number of adenomas, the size of polyp, and the location of polyp? 
3) Is there an association between procedure time and 2-person technique? 
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4) Is there an association between procedure time and sedation type? 
3.1.2 Study hypotheses 
1) Hypotheses related to the hands-on 2-person technique: 
a) The likelihood of detecting a/an polyp/adenoma by PCPs using 2-person 
technique and specialists using 2-person technique is higher than specialists using 
1-person technique. (In this center, no PCP was permitt d to perform with the 
solo technique) 
b) More polyps/adenomas are detected by 2-person technique PCPs and specialists 
than solo-performing specialists. 
c) More number of small polyps will be detected by 2-person technique PCPs and 
specialists than that of solo performing specialists. 
d) The likelihood of detecting a right colon polyp will be higher for 2-person 
technique PCPs and specialists than solo-performing specialists. 
2) Hypotheses related to sedation type: 
a) Propofol sedation procedures are more likely to be associated with a/an 
polyp/adenoma detected than Midazolam-meperidine sedation procedures, and the 
increased likelihood will be observed for large and small polyps. 
b) Propofol sedation procedures are more likely to be associated with detection of 
right colon polyps than Midazolam-meperidine sedation procedures. 
3) Hypotheses related to procedure duration: 
a) Procedure time is longer with the 2-person technique than with 1-person 
technique after controlling for number of polyps found. 
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b) Procedure time is longer with the 2-person technique specialists than with 1-
person technique specialists after controlling for number of polyps found. 
4) Hypothesis related to the fourth research question: 
a) Propofol is associated with longer procedure time than Midazolam-meperidine as 
patient will be well sedated and the endoscopist can take time to complete the 
procedure carefully. 
3.2 Methodology 
3.2.1 Data source 
The setting of this study is a state-licensed ambulatory surgery center for 
endoscopy, South Carolina Medical Endoscopy Center (SCMEC), in Columbia, South 
Carolina. To begin with, the Center trains PCPs with d dactic instruction followed by a 
colonoscopy simulation model, and then initiates clini al procedure training with 
patients. The Center requires hands-on supervision and participation by the specialist for 
the first 140 procedures (the ASGE-prescribed level for gastroenterology residents to be 
credentialed for independent colonoscopy performance, Faigel 2007). The 
specialist/expert (gastroenterologist/colorectal surgeon) initially provides the PCP with 
hands-on assistance to push the scope and assist with tip manipulation and polypectomy 
up to 140 procedures. The frequency of manual assist nce by the expert/specialist is 
gradually reduced, and transitioned to the verbal assistance to navigate difficult colonic 
segments and/or diverticula. Finally, post-training the PCP performs without specialist 
oversight, and the specialist intervention is limited o therapeutic assistance when called 
upon to remove advanced adenomas, polyps at difficult locations, control bleeding, 
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and/or manage spasms. The Study Center’s training of PCPs was started in 2001, and 54 
PCPs were trained as of February 4, 2011.  
The SCMEC protocol requires a 2-person technique for all PCPs regardless of 
training status, i.e., even after training. All PCPs have to bring their patients to the 
SCMEC and cannot perform the procedure at their own ffices. The SCMEC innovative 
protocol has the following unique features: a) (After training procedures are completed) 
An endoscopy technician advances the colonoscope whil the physician manipulates the 
scope tip for polyp search and removal. This method minimizes the missing of polyps 
due to physician's motor fatigue, confers the dexterity of two “right” hands for polyp 
search and removal, and ensures more persons watching he video screen for polyps. b) 
Since April 2006, propofol sedation occurs instead of the conventional midazolam-
meperidine combination sedation, c) Gradual insertion and withdrawal for polyp search 
and removal maximizes the coverage of the colonic mu osal surface, d) A minimum of 3 
persons watch the video-screen to identify abnormal mucosa and polyps to assist the 
performing physician. 
This is a retrospective study of all screening colon scopies performed between 
September 4, 2001, through February 4, 2011, at the SCMEC. Over the study period, 59 
physicians performed the procedures included. The Center’s innovative protocol of 2-
person technique was consistently complied by 57 physicians (54 PCPs and 3 specialists), 
PCPs are defined as those with family medicine, intrnal medicine, pediatrics or 
obstetrics/gynecology specializations. Two specialists (one colorectal surgeon and one 
general surgeon during one year) did not follow the 2-person technique.  
3.2.2 Approaches to test the study hypotheses 
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We first tested the effect of sedation type on 59 physicians performance in terms 
of procedure time, cecum intubation, polyp and adenoma detection before (Midazolam-
meperidine sedation) and after the execution of propofol sedation at a procedure cut point 
of April, 2006. Our hypothesis regarding the effect of he two-person technique features 
of the new protocol is that specialists should perform better than PCPs within the two-
person technique procedures in terms of our quality indicators. To validate the 
hypothesis, quality indicators were compared of twospecialists who did not follow the 
innovative protocol with three specialists who did, and PCPs (all 2-person technique). 
The effect of the 2-person technique within specialists was also evaluated. Two 
specialists not following the new protocol were compared with the remaining specialist 
endoscopists who followed the protocol.  
The hypothesis regarding sedation type is that patients sedated by propofol should 
have better outcomes than those sedated by Midazolam-meperidine in terms of our 
selected quality indicators. To validate the hypothesis, the quality indicators of patients 
sedated by Midazolam-meperidine were compared with pa ients sedated by propofol.  
The quality indicators of interest were procedure time, cecum intubation rate, 
likelihood of polyp detection and adenoma detection, the number of polyps/adenomas 
detected per screened person (MNP/MNA), polyp size, and detection of right-sided 
polyps. MNP and MNA were to show the total polyps/adenomas each physician found 
among their procedures calculated into a mean per scr ened person. The size of the polyp 
is the diameter, categorized as ≦5mm, 6 – 9 mm, or 10+ mm. Polyp location refers to 
anatomic location in the colon, left colon or right colon. 
3.2.3 Regression Models 
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In selecting the multivariate analysis method, we had to ensure that the statistical 
analyses address non-independence of data due to clus ering of patients within physician. 
Random-effect regression models address such clustering by incorporating a random 
effect for physicians and fixed effects for other covariates in the model. Alternatively, 
fixed-effects regression models incorporate a fixed effect for each physician, though this 
approach is more difficult to translate to data from ther physicians.  Finally, generalized 
estimating equations (GEE) modeling, assumes a specific correlation structure for the 
repeated measures data per physician.  We modeled our data using GEE Models for 
which we assumed an exchangeable correlation structure.  This structure assumes that 
any two observations from different physicians are uncorrelated, and any two 
observations from the same physician are the same vlu  (no matter which physician).  
Our inference was based on statistics constructed from the modified sandwich variance 
estimator so that inference is robust to any within-physician correlation structure no 
matter how different from exchangeable. GEE was used because it accommodates within-
physician correlation without focusing attention on that aspect of the data analysis. The 
within physician correlation is treated as an ancillary problem to be accounted for but not 
of profound interest.  When using the exchangeable correlation structure for a linear 
model, the regression parameters of the GEE are algebraically equivalent to the 
correlation among patients within a physician panel.  The same is not quite true for 
inference of regression parameters from the logistic GEE and logistic random effect 
models. GEE was determined to be the optimum modeling tool for these analyses. 
a. Testing the association of a protocol feature with procedure time 
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GEE is used to model covariates in a generalized linear model with either 
unknown or expected correlation between outcomes. It i  described as follows: 
“It is a method of analyzing correlated data that otherwise could be modeled as a 
generalized linear model. GEEs have become an important strategy in the analysis of 
correlated data. These data sets can arise from longitudinal studies, in which subjects 
are measured at different points in time, or from clustering, in which measurements 
are taken on subjects who share a common characteristic such as belonging to the 
same litter.” (SAS online support) 
Linear GEE regression was used to study the association between the procedure 
time and our variables of interest. The hypotheses tested using this regression method 
were as follows: 
1) Patients subjected to the 2-person technique will have longer procedure times 
than under the 1-person technique after controlling for the number of polyps found. (This 
is because having an extra person hands-on serves to r inforce the Center’s requirement 
of gradual insertion and withdrawal of the colonoscope to carefully work with the folds 
and search for polyps covering all possible mucosal surfaces.) 
2) Within the 2-person technique group, PCPs will have longer procedure times 
than specialists after controlling for the number of p lyps found. (This is expected 
because PCPs may have less skill than specialists in navigating the colonoscope) 
3) Propofol-sedated patients will have longer procedur  times than midazolam-
meperidine-sedated patients after controlling for the number of polyps found. (This is 
likely because of better pain control under propofol. Thus the need to rapidly wind down 
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the procedure due to patient discomfort should be less common with propofol than with 
Midazolam-meperidine.) 
b. Testing the likelihood of finding any polyps/adenomas/advanced neoplasms  
Logistic GEE regression, a regression model for dichotomous dependent variables, 
was used to test the hypotheses regarding PDRs, ADRs, and advanced neoplasms 
detection rates. Hypotheses tested by GEE were: 
1) 2-person technique procedures will be more likely to have at least one 
polyp/adenoma/advanced neoplasm detected than 1-person technique procedures, 
2) Within the 2-person technique group, PCPs will be as likely as specialists to detect at 
least one polyp/adenoma/advanced neoplasm, 
3) Propofol sedated patients will be more likely to have at least one 
polyp/adenoma/advanced neoplasm detected than the Midazolam-meperidine sedated 
group. 
c. Testing the likelihood of finding additional polyps and adenomas, and the 
likelihood of finding progressively smaller polyps as well as the likelihood of 
right colon polyps 
Ordered logistic GEE regression, a regression modeling method for ordinal 
dependent variables was used to test whether the likelihood of finding each additional 
polyp/adenoma in a patient, the likelihood of findig progressively smaller polyps, and 
the likelihood of finding a right colon polyp, increased with the use of the 2-person 
technique.  
Our study hypothesized that compared with the 1-person technique, 2-person 
technique procedures are more likely to be associated with at least one polyp found 
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relative to zero polyps. This relationship remains the same when moving to the next 
comparison level, i.e. finding 2 polys vs. only one polyp. Likewise, for the size of the 
polyp, we hypothesize that compared to the 1-person technique, 2-person technique 
procedures are more likely to be associated with a sm ll (≦5 mm) polyp found relative to 
a medium (6-9 mm) polyp. The relationship is hypothesized to be similar for the next 
level of polyp size, that compared to the 1-person technique,2-person technique 
procedures are more likely to be associated with a medium (6-9 mm) polyp found relative 
to a large (10+mm) polyp. Finally, for polyp anatomic location, we hypothesize that 
relative to the 1-person technique procedures, 2-person technique procedures are more 
likely to be associated with at least one right colon polyp found relative to only left colon 
polyps found. 
Regarding sedation type, the assumptions is that compared to midazolam-
meperidine sedation, propofol-sedated procedures are mo e likely to be associated with at 
least one polyp found relative to zero polyps. The same association carries to the next 
level as explained above. As for polyp size, we hypothesize that compared to the 
midazolam-meperidine sedation, propofol-sedated procedures are more likely to be 
associated with detecting small (≦5 mm) polyp(s) relative to medium (6-9 mm) polyps. 
The relationship remains the same on the next level, which means compared to the 
midazolam-meperidine sedated group of procedures, th  propofol sedated procedures are 
more likely to be associated with finding a medium (6-9 mm) polyp found relative to 
finding only a large (10+ mm) polyp. Lastly, compared to midazolam-meperidine 
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sedation, propofol-sedated procedures are more likely to be associated with finding at 
least one right colon polyp relative to only left colon polyps found. 
3.3  Preparing and cleaning the data 
3.3.1 Data extraction and sample data 
A total of four datasets without personal identifying information on all 
colonoscopies conducted during September 4, 2001 and February 4, 2011were extracted 
into Microsoft EXCEL from the SCMEC computers into University of South Carolina 
(USC) computers. The four datasets were physician dataset, procedure dataset, polyp 
dataset, patient dataset (appointment and race gender information stored in Mysys and 
FoxPro at SCMEC). 
The physician dataset includes the information related to the physician, such as 
the physician name, the gender, the race, age as of 2007, the year of graduation, the area 
of specialty, and board certification. The procedur dataset includes the clinical 
procedure notes: time of scope insert and time out of anus, the time of staring the 
withdrawal (when cecal was viewed), was the sequential umber of this procedure under 
the training process, and the section of the colon up to which the colonoscope was 
advanced to for the patient in this procedure, the procedure date, and was this procedure 
performed by a specialist or a PCP etc.  
The polyp dataset contains the histology of the poly , was this polyp an adenoma, 
the size of the polyp, the hyperplasia percentage/sev rity of the polyp, dysplasia level, 
was the polyp removed, how was the polyp removed, an  location of the polyp. The 
patient dataset contains data on patient age as of the procedure date, gender, race, and 
date of birth. 
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3.3.2 Linking, clearing and acquiring missing data 
All datasets were linked by the procedure identifier (ID). In addition to the procedure 
ID, there is a patient ID linking multiple procedures for the same patient. In this study, 
we used data on only the first screening colonoscopies of each patient (initial 
colonoscopy).Over 10,000 patient charts were reviewed to fill in missing data and to 
resolve typographical errors/discrepant information between the datasets. Updates were 
carried out in the summer and fall 2011, and the summer and fall of 2012. Variables 
corss-checked were patient date of birth, procedure at , bowel preparation status, 
procedure time points (time of insertion, viewing cecum, and withdrawal), and all 
variables of the polyp data to verify a polyp characteristics.  
After merging the above datasets and missing data/discrepant data entered, duplicates 
were removed, cancelled patient appointments were removed, procedures that were 
performed by the SCMEC director at a neighboring hospital were removed, and variables 
were renamed and labeled. Some variables were recoded/extracted from text fields, some 
of the data categories were recoded, such as dysplasia level recode, which accommodated 
information from two variable fields, pathologytext and path_results. In October 2012, 
two rounds of manual review of text fields and recoding of polyp_results were done to 
retrieve missing data for 4,746 polyps due to the mis-categorized information by SCMEC 
staff in a different variable field in the polyp dataset. After cleaning the procedure and 
polyp datasets, we summarized the polyp data by procedure and linked the summarized 
polyp information to procedure dataset by procedure ID for studying indicators of 
procedure performance.  
3.4  Inclusion and exclusion criteria 
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We selected only screening colonoscopies of average risk population consistent 
with the objective of this study. Therefore, we first excluded the second and later 
procedures for each patient. After extracting initial procedures, patients aged less than 30 
years or older than 90 years were excluded because the age groups are not the target of 
routine screening as per USPSTF screening guidelines. I  addition to age exclusion, we 
excluded patients with prior history of colon/rectum resection because they are no longer 
in the average risk pool once they were diagnosed a colon/rectum related diseases.  
3.5  Sample selection 
Retrospective data on all 26,523 colonoscopy procedures performed from 
September 4, 2001 to February 4, 2011 were evaluated for selection of screening 
colonoscopies (the first colonoscopy of the patient). A total of 5,611 second and later 
procedures were excluded. Of the 20,912 patients with an initial colonoscopy, we 
excluded patients less than 30 years of age or oldethan 90 years (342 patients) and those 
with prior history of colon/rectum resection (30 patients). Figure 3-1 shows the sample 
selection flow chart with exclusions by the above criteria leading up to the study sample 
of 20,540 consecutive colonoscopies conducted by 54 PCPs and 5 specialists during the 




Figure 3-1 Sample Selection Flowchart 
3.6  Defining the key variables of interest 
To identify patients with and without polyps, we summarized polyps by patientid 
in polyp dataset. Below are list of our study variables: 
• Patient age 
• Patient race 
• Patient gender  
• Sedation type 




as of February 4, 
20,912 initial 
20,570 patients with initial 
colonoscopy 30-89 years 
30 excludes dues to prior 
history of colon/rectum 
resection 
20,540 study eligible 
15,203 patients 
with 2-person 
4,773 patients with 2-
person technique 
604 patients with 1-
person technique 
342 <30 years & ≥90 years 
5,611 2nd and later procedures 
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• Number of polyp found per subject 
• Number of adenoma found per subject 
• Procedure time 
• Bowel preparation 
Quality indicators 
The procedure time, named Timeproc is calculated from the original downloaded 
fields from SCMEC – starttime and endtime. Time during the day was extracted as 
starttime and endtime usng the raw variables ScopeIn and Scopeout. The interval in 
seconds between ScopeIn and ScopeOut was taken and divided by 60 to calculate  
TimeProc in minutes.  
For polypsize, variable polypsizemm is used to categorize polyps into three 
groups, “≤5mm”, “6-9mm”, and “10+mm”. For polyp location, PolypLocation was the 
original variable used to create the intermediate vriables. Polyp location was defined as 
proximal if located in the cecum, ascending colon, hepatic flexure, and transverse colon, 
and as distal if located in the splenic flexure, descending colon, sigmoid colon, or rectum. 
For those located in the proximal, we coded as “right colon”, for the remaining, “left 
colon” . 
Adenoma and polyp detection rate 
Adenoma detection is our key dependent variable to define the quality. To detect 
adenomas (which are identified by pathologic examintio  of polyps), endoscopists must 
first find the polyps during the colonoscopy, classify the polyp by gross appearance, and 
take part of the lesion to lab for biopsy to confirm the histology of the polyp. Therefore, 
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we first study the polyp detection and then proceed to adenoma detection as our key 
variables of interest.  
Polyp detection rate is defined as the percentage of patients with at least one 
polyp found. Each polyp has a polypid and a procedureid to link to the patient it belongs 
to. To identify the likelihood of a patient having a polyp, we summarized the polyps in 
each patient into a polyp dataset. If a patient ID exists in the polyp summary dataset, the 
patient was coded as “Yes” for the polyps variable in the procedure dataset, and  if not, it 
was coded“No”. To calculate the polyp detection rate, patients with polyps equal to 
“Yes” are divided by total patients. Adenoma detection rate is calculated by the same 
process. 
For the number of polyps found per subject, polyps were summarized within each 
patient using patient ID in the polyp dataset and the variable with count of polyps was 
merged into procedure dataset as SumPolyps using the patientid. A similar process was 
used for the number of adenomas found per subject, named SumAdenomas. 
Protocol type 
The protocol type was classified at the level of provider using the providerID 
from SCMEC. Per SCMEC, providerID equal to 56 and 64 were classified as 1-person 
technique specialists, whereas providerID equal to 1, 22 and 59 were classified as 2-
person technique specialists, and the remaining physicians were PCPs all using 2-person 
technique. Procedures by these respective physician were thus assigned to the protocol 




The sedation type is categorized by procedure date.Every procedure conducted 
before April 1, 2006 was categorized as Midazolam-meperidine sedated procedure, while 
April 1, 2006 and after were propofol-sedated procedur . 
Control variables classified 
Patient age was calculated from patient date of birth downloaded from the 
SCMEC’s administrative billing system. The continuous variable of age was recoded into 
four age groups: <50 years, 50-59 years, 60-69 years, and 70-89 years. Patient gender 
was downloaded from the SCMEC’s administrative system coded as male and female. 
Patient race is coded as Whites, Blacks, Other and unknown (missing information). 
The bowel preparation status, bowelprep, is based on a field directly downloaded 
from SCMEC data system called ColPrep. If ColPrep was equal to missing, it remains 
missing in bowelprep. If ColPrep equal to “excellent”, it remains the same in bowelprep. 
If ColPrep indicated “fair” or “good”, it was re-coded “fair” in bowelprep. If ColPrep 
equal to “poor”, it remains the same in bowelprep. 
The variable to classify training procedure or not, amed training is based on a 
field directly downloaded from SCMEC administrative system called ColPCPSeq. All 
primary care physicians had their cumulative procedur s assigned for each procedure 
because their very first training procedures started at the study center. Specialists do not 
qualify for procedure volume variable and have a missing value in this field because all 
of the specialists completed their first 140 training procedures before getting credentialed 
in colonoscopy during their training. Therefore, if ColPCPSeq equals to “missing” or 
more than 140, training of this physician will be coded as “No (0)”. If ColPCPSeq less 
than or equal to 140, training value is “Yes (1)”. 
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Interaction terms to be tested 
We further studied the interaction between bowel prpa ation status (excellent, 
fair and poor) and sedation type. To test the effect of interaction six categories were 
created based on bowelprep and sedation variables, which are Midazolam-
meperidine/Poor, Midazolam-meperidine/Fair, Midazolm-meperidine /Excellent, 
Propofol/Poor, Propofol/Fair, Propofol/Excellent. 
The cecal intubation rate, named cecalintub, is coded based on original fields 
downloaded from SCMEC – termileumintubated and advnacedupto. If 
termileumintubated equal to “Yes” or advancedupto equal to “the cecum”, then 
cecalintub equal to “Yes.” To calculate the cecal intubation rate, patients with cecalintub 
equal to “Yes” are divided by total patients. 
3.7  Data analysis 
3.7.1 Unit of analysis 
To address the research questions, the unit of analysis is the patient. Because there 
is only one procedure per patient in our sample, th number of colonoscopies” implies the 
same number of patients. 
3.7.2 Study period 
Retrospective data on 20,540 screening colonoscopies from a licensed ambulatory 
surgery center for endoscopy in South Carolina, performed during September 4, 2001 and 
February 4, 2011 were analyzed.  
3.7.3 Table of variables 
The variables used are listed in Table 3-1. A total f twelve variables were used 
from the procedure dataset and two variables were ext acted from the polyp dataset. The 
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variables are three categorical variables (patient age, patient race, and protocol type), six 
dichotomous variables (patient gender, polyp found (or not), adenoma found, sedation 
type, good bowel preparation (yes/no), and training procedure (yes/no), and three 
continuous variables (number of polyps found in a patient, number of adenomas found in 
a patient, and procedure time).  
Two variables were extracted from polyp dataset, which were polyp size in 
millimeter and polyp location. Each was summarized into procedure data set based on 
procedureID, and hierarchically categorized into “npolyp”, “at least one small polyp 
(≤5mm)”, “only medium polyps (6-9mm)”, and “only large polyps (10+mm) found” in a 
patient; and “no polyp”, “at least one right-sided polyp found” or “only left-sided polyps 
found” in a patient.  
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Table 3-1 variables of interest 




Variable categories Type of 
variable 
Procedure dataset 
PatAgeGrp Patient age 4 <50 years, 50-59 
years, 60-69 years, 
70-89 years 
Categorical 
PatGender Patient gender 2 Male, Female Dichotomous 
PatRace Patient race 3 White, Black, Other Categorical 






polyps Does this patient 
have any polyps? 
2 Yes, No Dichotomous 
adenoma Does this patient 
have any 
adenomas? 
2 Yes, No Dichotomous 
SumPolyps The number of 
polyps detected for 
this patient 
NA NA Continuous 
SumAdenoma The number of 
adenomas detected 
for this patient 
NA NA Continuous 
TimeProc Total procedure 
time 
NA NA Continuous 
Sedation Sedation type 2 Midazolam-
meperdine, Propofol 
Dichotomous 
bowelprepgood Bowel preparation 
status 
2 Yes: If it was 
Excellent, Good, Fair 
bowel preparation 
status 






Is procedure a PCP 
training 
procedure? (<140th 
procedure for the 
PCP) 
2 Yes: If it was 1-139th 
procedure for the 
PCP 
No: >140th procedure 




Polypsizemm Polyp size in mm 4 No polyp, ≦5 mm, 6-
9 mm, 10+ mm 
Ordinal  
Polyploc Whether the polyp 3 No polyp, left colon, Ordinal 
83 
 
site is in the left 
colon or the right 
colon? 
right colon 
3.8  Statistical analysis 
To answer the research questions, statistical models w re run to examine 
associations between the independent variables of interest and screening colonoscopy 
quality indicators (dependent variables). Indicators studied are defined earlier. For the 
protocol type, we compared the 1-person technique specialists group and the 2-person 
technique specialists group with 2-person technique PCPs group. As for the sedation 
type, we compared the propofol sedation procedures with midazolam-meperidine 
sedation procedures. In each model, we controlled for bowel preparation status because 
bowel preparation is a patient-dependent variable that greatly influences the quality 
indicators. GEE modeling was used to account for patients clustered within physician. 
SAS version 9.3 is used. 
3.8.1 Model 1: Procedure time (continuous variable) 
A linear GEE regression model was used to investigate protocol type/sedation type using 
“proc genmod” syntax in SAS. 
Yprocedure time=β0 + β1
*2-person technique/physician specialty + β2
*patient age + 
β3
*patient gender + β4
*patient race + β5
* number of polyps found + β6
* sedation type 
+ β7
* bowel preparation + β8*sedation type*bowel preparation + β9
*training 
procedure status + εerror  
This linear GEE regression model tested the associati n between protocol type (1-
person technique vs. 2-person technique) and the sedation type and the procedure 
durations controlling for the remaining variables.  
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For all models we tested the interaction term of sedation type with bowel 
preparation and because it was statistically significant, we compared procedure times for 
Midazolam-meperidine/Fair (bowel prep), Midazolam-meperidine/Excellent, 
Propofol/Poor, Propofol/Fair, and Propofol/Excellent to Midazolam-meperidine/Poor. 
However on comparing the models with the above categori s with the two variables 
modeled separately, the results were not substantially d fferent, but readily interpretable. 
Hence the latter results were used for interpretation.  
3.8.2 Model 2: Polyp detection likelihood (dichotomous variable)  
A logistic GEE regression model was used to investigate protocol type/sedation type 
using “proc genmod” syntax in SAS. 
Ypolyp detected =β0 + β1
*2-person technique/physician specialty + β2
*patient age + 
β3
*patient gender + β4
*patient race + β5
* sedation type + β6
* bowel preparation + 
β7*sedation type*bowel preparation + β8
*training procedure status + εerror  
This logistic GEE regression model tested the associati n between protocol type 
(1-person technique vs. 2-person technique) and the sedation type and the polyp detection 
controlling for the remaining variables.  
3.8.3 Model 3: adenoma detection likelihood (dichotomous variable)  
A logistic GEE regression model was used to investigate protocol type/sedation type 
using “proc genmod” syntax in SAS. 
Yadenoma detected=β0 + β1
*2-person technique/physician specialty + β2
*patient age + 
β3
*patient gender + β4
*patient race + β5
*sedation type + β6
* bowel preparation + 
β7
*sedation type*bowel preparation + β8
*training procedure status+ εerror  
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This logistic GEE regression model tested the associati n between protocol type 
(1-person technique vs. 2-person technique) and the sedation type and the adenoma 
detection controlling for the remaining variables.  
3.8.4 Model 4: Advanced neoplasms detection likelihood (dichotomous variable)  
A logistic GEE regression model was used to investigate protocol type/sedation type 
using “proc genmod” syntax in SAS. 
Yadvanced neoplasms detected=β0 + β1
*2-person technique/physician specialty + β2
*patient 
age + β3
*patient gender + β4
*patient race + β5
*sedation type + β6
* bowel preparation 
+ β7
*sedation type*bowel preparation + β8
*training procedure status+ εerror  
This logistic GEE regression model tested the associati n between protocol type 
(1-person technique vs. 2-person technique)/sedation type and advanced neoplasm 
detection likelihood controlling for the remaining variables.  
3.8.5 Model 5: likelihood of finding additional polyps (ordinal variable) 
An ordered logistic GEE regression model to investigate protocol type/sedation type 
using “proc genmod” syntax with “dist=multinomial” option in SAS. 
Ynumber of polyps found =β0 + β1
*2-person technique/physician specialty + β2
*patient age + 
β3
*patient gender + β4
*patient race + β5
* sedation type + β6
* bowel preparation + β7
* 
sedation type*bowel preparation+ β8
*training procedure status+ εerror  
This ordered logistic GEE regression model tested th  association between 
protocol type (1-person technique vs. 2-person technique) and the sedation type and 




3.8.6 Model 6: likelihood of finding additional adenomas (ordinal variable) 
An ordered logistic GEE regression model to investigate protocol type/sedation type 
using “proc genmod” syntax with “dist=multinomial” option in SAS. 
Ynumber of adenomas found =β0 + β1
*2-person technique/physician specialty + β2
*patient age 
+ β3
*patient gender + β4
*patient race + β5
* sedation type + β6
* bowel preparation + 
β7
* sedation type*bowel preparation+ β8
*training procedure status+ εerror  
This ordered logistic GEE regression model will test he association between 
protocol type (1-person technique vs. 2-person technique) and the sedation type and the 
ability of finding an additional adenoma in a patien , which controls for the remaining 
variables.  
3.8.7 Model 7: right colon polyps (ordinal variable) likelihood 
An ordered logistic GEE regression model was used to investigate protocol type/sedation 
type using “proc genmod” syntax with “dist=multinomial” option in SAS. 
Yat least one right colon polyp detected=β0 + β1
*2-person technique/physician specialty + 
β2
*patient age + β3
*patient gender + β4
*patient race + β5
* sedation type + β6
* bowel 
preparation + β7
* sedation type*bowel preparation + β8
*training procedure status + 
εerror  
This ordered logistic GEE regression model tested th  association between 
protocol type (1-person technique vs. 2-person technique PCPs and 2-person technique 
specialists) and sedation type vs. the likelihood of a right colon polyp detection, which 
controls for the remaining variables.  
3.8.8 Model 8: likelihood of finding increasingly smaller polyps (ordinal variable) 
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An ordinal logistic GEE regression model to investiga e protocol type/sedation type using 
“proc genmod” syntax with “dist=multinomial” option i  SAS. 
Ypolyp size =β0 + β1
*2-person technique/physician specialty + β2
*patient age + 
β3
*patient gender + β4
*patient race + β5
* sedation type + β6
* bowel preparation + β7
* 
sedation type*bowel preparation+ β8
*training procedure status+ εerror  
This ordered logistic GEE regression model tested th  association between 
protocol type (1-person technique vs. 2-person technique) and the sedation type and the 
likelihood of finding a small adenoma vs. medium adenoma and large adenoma in a 
patient controlling for the remaining variables.  
3.9  Preliminary review of sample distribution by key dependent variables 
Sample distributions for the number of polyps and adenomas found in each 
subject were cross tabulated by protocol type and sedation type in order to assess the 
suitability of the variable categories for the planned analyses considering statistical power 
and model convergence potential. The distributions and the subsequent changes in 
variable categorization for the final analyses are presented below. 
Table 3-2 shows that the number of polyps was missing for 117 patients (similarly 
for the number of adenomas found in Table 3-5). Majority of the patients had no polyps 
(38.5%), one polyp (31.5%), two polyps (16.5%), andthree polyps (8%). Beyond three 
polyps, the sample percentage (6%) is low. Therefore, we categorized patients into four 
levels: 0, 1, 2, and 3+. Table 3-3 shows the breakdown of these four categories by 
protocol type (1-person technique vs. 2-person technique with physician specialty). Based 
on the distribution, the percentages in each cell appe r reasonable except for 39 patients 
with three or more polyps under the 1-person technique specialist group which could 
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breakdown into zero cells in multiple regression analysis. Table 3-4 shows the 
distribution of sedation type (Midazolam-meperidine vs. propofol) by number of polyps 
found in four categories. The range was 29% to 39% of patients in each sedation type 
with zero polyps or one polyp. The percentages of patients with zero or one polyp in 
Midazolam-meperidine sedation were higher than propofol sedation, however, the pattern 
was reversed for patients with two polyps and three and more polyps which are higher in 
those with propofol sedation. 
Table 3-5 shows the distribution of the number of adenomas found in a patient, 
117 patients with missing polyp information. Table 3-6 and 3-7 showed the breakdown 
by protocol type (1-person technique vs. 2-person technique with physician specialty) and 
sedation type (Midazolam-meperidine vs. propofol). The patterns mostly mirrored the 
number of polyps found.   
Table 3-8 shows the distribution of the study sample by protocol type and 
sedation type: 604 patients (3%) were served by 1-person technique specialist (two 
specialists), 4,733 patients (23%) were served by 2-person technique specialist (three 
specialists), and the majority of patients (15,203, 74%) were served by 2-person 
technique PCP (54 PCPs). About 55% of the patients were provided Midazolam-
meperidine sedation and 45% of the patients provided propofol sedation. Most patients 
were aged 50 to 59 years (45%), followed by 60 to 69 years (25%), <50 years (18%) and 
70 to 89 years (12%). Slightly more females (54%) and Blacks (52%) were represented in 
our study sample. 
Table 3-9 and 3-10 shows the distribution of dependent variables by the major 
independent variables of interest. These tables show t e distribution of the sample in each 
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cell relevant for multiple regression analysis. Forexample patients under 1-person 
technique specialist with three or more polyps broken down by sedation type yielded only 
five patients under Midazolam-meperidine sedation group. The sample distribution by 
number of adenomas found is more extreme with only three patient in this category and 
11 patients under the propofol sedation group. 
The preliminary reviews of the sample distributions guided our scheme of 




Table 3-2 Distribution of the number of polyps found per subject 
Polyps found per subject Frequency  Percentage(%)  
Missing                    117 0.57 
0 7,772 37.84 
1 6,383 31.08 
2 3,346 16.29 
3 1,634 7.96 
4 716 3.49 
5 323 1.57 
6 134 0.65 
7 64 0.31 
8 25 0.12 
9 15 0.07 
10 3 0.01 
11 6 0.03 
13 1 0.00 
14 1 0.00 
Table 3-3 Distribution of the number of polyps found per subject by protocol type 








Missing 2 (0.33%) 42 (0.89%) 73 (0.48%) 
0 322 (53.31%) 1713 (36.19%) 5737 (37.74%) 
1 174 (28.81%) 1480 (31.27%) 4729 (31.11%) 
2 67 (11.09%) 765 (16.16%) 2514 (16.54%) 
3+ 39 (6.46%) 733 (15.49%) 2150 (14.14%) 
 
Table 3-4 Distribution of the number of polyps found per subject by sedation type 
Polyps found per subject Midazolam-meperidine Propofol 
Missing 83 (0.74%) 34 (0.37%) 
0 4,386 (38.93%) 3,386 (36.51%) 
1 3,726 (33.07%) 2,657 (28.65%) 
2 1,791 (15.90%) 1,555 (16.77%) 
3+ 1,280 (11.36%) 1,642 (17.71%) 
Table 3-5 Distribution of the number of adenomas found per subject 
Adenomas found per 
subject 
Frequency  Percentage(%)  
Missing                 117 0.57 
0 14,003 68.17 
1 4,054 19.74 
2 1,456 7.09 
3 557 2.71 
4 225 1.10 
5 73 0.36 
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6 29 0.14 
7 13 0.06 
8 7 0.03 
9 5 0.02 
11 1 0.00 
 
Table 3-6 distribution of the number of adenomas found per subject by protocol type 








Missing 2 (0.33%) 42 (0.89%) 73 (0.48%) 
0 459 (75.99%) 3,245 (68.56%) 10,299 (67.74%) 
1 101 (16.72%) 911 (19.25%) 3,042 (20.01%) 
2 28 (4.64%) 353 (7.46%) 1,075 (7.07%) 
3+ 14 (2.32%) 182 (3.85%) 714 (4.70%) 
 
Table 3-7 Distribution of the number of adenomas found per subject by sedation type 
Adenomas found per subject Midazolam-meperidine Propofol 
Missing 83 (0.74%) 34 (0.37%) 
0 7,706 (68.40%) 6,297 (67.90%) 
1 2,224 (19.74%) 1,830 (19.73%) 
2 814 (7.23%) 642 (6.92%) 
3+ 439 (3.90%) 471 (5.08%) 
Table 3-8 Distribution of study sample by key independent variables 
 No. patients 
n (%) 
Protocol type  No. performing physicians
1-person technique specialist 604(2.94) 2 
2-person technique specialist 4,733(23.04) 3 
2-person technique PCP 15,203(74.02) 54 
Sedation type 
   Midazolam-meperidine 11,266(54.85) 
   Propofol 9,274(45.15) 
Patient age 
   <50 years 3,792(18.46) 
   50-59 years 9,138(44.49) 
   60-69 years 5,066(24.66) 
   70-89 years 2,544(12.39) 
Patient gender* 
   Male 9,390(45.72) 




   Whites 9,139(44.49) 
   Blacks 10,623(51.72) 
   Other 682(3.32) 
Number of polyps found** 
   0 7,772(37.84) 
   1 6,383(31.08) 
   2 3,346(16.29) 
   3+ 2,922(14.23) 
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Chapter 4 CONCLUSIONS AND DISCUSSION 
In lieu of chapter 4 and 5, the following manuscripts are included: 
Manuscript #1: Does a hands-on 2-person colonoscopy technique affect screening 
colonoscopy quality and outcomes of primary care physicians and specialists? 
Abstract 
Background: Colorectal cancer (CRC) is the third most prevalent ca cer and 2nd leading 
cause of cancer death in the U.S. Colonoscopy has been recommended as the preferred 
screening method to prevent cancer by removing polyps before they transform into 
cancer. Although the effectiveness of colonoscopy in preventing CRC is documented, 
screening colonoscopy coverage in the US population remains low. This is partly due to 
low colonoscopy capacity due to a shortage of gastroen erologists (GI). When the supply 
of GIs is limited, training primary care physicians (PCP) effectively in screening 
colonoscopy with quality assurance safeguards could be a solution to address the gap.   
Objectives: To assess if the “hands-on” 2-person technique innovative clinical protocol 
enables the quality of PCP-performed colnoscopies to be comparable to specialist-
performed colonoscopies. 
Methods: The study center, a state-licensed ambulatory surgery center, the South 
Carolina Medical Endoscopy Center (SCMEC) requires an innovative 2-person technique 
protocol for all PCPs all the time regardless of trained status. 59 physicians performed 
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colonoscopies, the 2-person technique was consistently complied with by 57 physicians 
(54 PCPs and 3 specialists), and 1-person technique was used by 2 non PCPs (one 
colorectal surgeon and one general surgeon). 2-person technique will be examined for its 
effect on the quality of screening colonoscopies. The study hypotheses is that screening 
colonoscopy quality among the 2-person protocol group is better than among solo 
technique protocol group. Only the screening colonoscopy procedures of all patients 
served during this period. Subsequent (surveillance) procedures are not included as lesion 
rates may be different at these procedures. 
Results: About 3% of the patients were served by 1-person technique specialists, 23% by 
2-person technique specialists, and the remaining 74% by 2-person technique PCPs. The 
likelihood of polyp detection was highest for the 2-person technique specialists (adjusted 
OR=1.39) compared to 2-person technique PCPs, and 1-person technique specialists were 
79% less likely to detect a polyp(s) relative to 2-person technique PCPs (adjusted 
OR=0.56). The effect is sustained for adenoma detection and for the likelihood of finding 
each additional polyp/adenoma. Similarly, 2-person technique specialists were 
significantly more likely to detect a right colon polyp than solo specialists (estimated OR: 
2.42). The likelihood of finding small polyp(s) mirro s the pattern of quality indicators 
described above. 
The adjusted procedure time is longest for 2-person technique PCPs. Compared to 2-
person technique PCPs, 2-person technique specialists t ke an average of 1.01 minutes 
(p=.184) shorter, while 1-person technique specialists use 3.77 minutes (p<.0001) shorter 
time to finish the procedure controlling for other factors.  
97 
 
Conclusions: This study finds that an innovation of a hands-on 2-person technique is 
associated with superior colonoscopy performance and lesion detection outcomes, and 
that by every discriminating measure, the results wi h the 2-person technique are 
superior, and consistent across measures. A study limitation is the small numbers of 2 





 Colorectal cancer (CRC) is the 3rd most prevalent cancer and 2nd leading cause of 
cancer death in the U.S. (SEER 2013). Colonoscopy has been recommended as the 
preferred screening method to prevent cancer by removing polyps before they transform 
into cancer (Rex 2000, Rex 2009, David 2006). Investigations have focused on adenoma 
clearance for reducing the risk of developing CRC (Kaminski 2010, Rex 2006, 
Lieberman 2007, Rex 2009). Although the effectiveness of colonoscopy in preventing 
CRC is documented, screening colonoscopy coverage in the US population remains low. 
This is partly due to low colonoscopy capacity due to a shortage of gastroenterologists 
(GIs), the major physician type performing screening colonoscopies. There is a big gap 
between GI supply and screening-eligible population (Seeff 2004). The annual new 
addition of the aging baby boomer population keeps the gap growing. Currently, there are 
about 13,968 board-certified GIs in the US, increasing annually by a count of 460 (less 
retirements) (ABIM 2013). To cover 100% of all screening-eligible US population, an 
estimated additional 7,340 GIs are needed (Vijan 2004).  
 When the supply of GIs is limited, trained primary care physicians (PCPs) could 
be a solution to address the gap, especially for underserved populations and regions 
(including rural areas). However, there is a widespr ad conviction that GIs being 
specialized perform better in their specialty functions than non-GIs. Some studies support 
this view. Non-GIs detected colorectal cancer in 87% of patients with a true cancer 
compared to 97.3% for GIs, although this study did not report the results adjusted for 
incomplete colonoscopy (Rex 1997). The authors also noted the lack of specific 
information on a major factor, namely non-GI providers’ training in colonoscopy, noting 
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that some of the study providers were self-trained an  others had variable (no 
documented) training. Examining colonoscopy quality by the ultimate outcome, CRC 
incidence following colonoscopy, two Canadian studies reported that following 
colonoscopies by non-GIs, the incidence of CRC was significantly higher compared to 
colonoscopies by GIs (Rabeneck 2010, Bressler 2007).  
In contrast, other research has shown that trained PCPs’ colonoscopy performance 
is comparable with GIs (Wilkins 2009, Xirasagar 2009). Cecum intubation rates for PCPs 
are documented at 96.5% (Edwards 2004), 89.2% (Wilkins 2009), and 98.1% (Xirasagar 
2010), and adenoma detection rates (ADR) at 22.5% (Edwards 2004), 28.9% (Wilkins 
2009), and 29.9% (Xirasagar 2010) provided by trained PCPs. Another series reported 
that PCPs had an ADR of 27.2% in men and 21.4% in women (Newman 2005).  
 Training PCPs effectively in screening colonoscopy with quality assurance 
safeguards may be a solution to cover the unscreened population. However, the uptake of 
colonoscopy by PCPs remains very low. Only 4% of graduating family medicine 
residents applied for colonoscopy credentialing in 2002 although half of the residency 
programs offered it, and only 18% of these programs had any candidate registered for the 
training (Wilkins 2004). While research has documented that “trained” PCPs can provide 
competent and safe colonoscopy (Edwards 2004, Newman 2005, Wilkins 2009, 
Xirasagar 2010), there is no documentation of the training process or the clinical 
protocols used by high-performing PCPs. This study presents the effectiveness of two 
protocol elements that were consistently used and documented at the endoscopy center to 
train PCPs. This protocol requires a hands-on 2-person technique, and includes other 
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elements to maximize colon surface inspection and to minimize the likelihood of missing 
polyps. 
 The 2-person technique used by the study center may be important because 
fatigue is a likely factor in adenoma detection rates, particularly as day progresses. 
Physicians’ ADR for afternoon procedures were signif cantly lower than for their own 
morning procedures (25.3% vs. 29.3%, p=.008) (Sanak 2009). The phenomenon of 
potentially lower quality performance due to fatigue is not limited to physicians. A study 
of the judicial system on the association between a favorable parole ruling and timing of 
the review (morning vs. afternoon) showed that judges were more likely to issue a 
favorable parole ruling in the mornings than in the aft rnoon, and immediately after the 
lunch break than in the later afternoons. The authors suggested that mental fatigue may 
be less at the beginning of the work day and after  short break for a meal or rest 
(Danziger 2011). In the case of colonoscopies, studies show that having a second 
observer in the procedure room is associated with hig er ADR/polyp detection rates 
(PDR), while one person performs the procedure (either the fellow or the attending GI), 
having the other as observer significantly increased th  ADR, 37% vs. 23% (p<.01) 
among screening colonoscopies (Rogart 2008). Another retrospective study that was not 
limited to screening colonoscopies reported that the detection rate for small adenoma 
(<5mm) was significantly higher when there is a second observer (25%vs. 17%, p=.001) 
noting that the rate and independent performance was higher for non-experienced fellows 
(second and third-year fellows) (Buchner 2011). 
 One advantage of having a second observer watching t e video screen is reduced 
likelihood of missed lesions due to visual fatigue. Supporting this explanation is one 
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study of a dedicated endoscopy nurse observing the video screen while the attending 
physician performed the screening colonoscopy. Thisstudy showed significantly more 
polyps detected per patient (adjusted OR=1.26) than when the attending physician 
performed solo with no observer (Aslanian 2013). 
 Experience level of the performer is an additional factor in performance quality. 
Peters et al (2010) reported that senior (third year) f llows supervised by the attending 
physician had almost double the ADRs of junior fellows (OR =1.7). A study from Korea 
noted that an endoscopy nurse observer of the video screen increased the likelihood of 
finding a lesion (OR =1.58 for polyp, and 1.47 for adenoma), when a fellow performed 
the procedure even though it was their 150th-500th procedures (OR =2.07), but no 
increase was observed for senior attending GIs (Lee2011). 
 In contrast to the above studies, a non-randomized prospective study conducted at 
a single-center reported no significant difference in polyp detection rates with an 
additional observer (single, attending GI alone 32%, second observer with fellow 
performing and attending GI supervising, 33%) and in adenoma detection rates (19.3% vs 
14.9%) (Eckardt 2009). When the GI performed solo they removed fewer diminutive (<5 
mm) hyperplastic polyps but relatively more adenomas th n fellows. 
 To our knowledge, the documented “2-person technique” studies have had similar 
protocols, namely, having a second observer. In our study setting, the protocol requires a 
“hands-on” 2-person technique to compensate for the lack of specialist training of the 
PCPs which may confer additional advantages that solo performing GIs do not have. 
Additionally prior studies on the 2-person technique protocols were also associated with 
the conventional polyp search limited to the phase of withdrawing the colonoscope. Our 
102 
 
study setting, in addition of the hands-on 2-person technique requires for PCPs, also 
requires gradual insertion and withdrawal of the colon scope with polyp search and 
removal during both insertion and withdrawal to maximize coverage of all mucosal 
surface. This latter requirement also minimizes chan es of “losing” a polyp that may be 
encountered during insertion but not traceable during the withdrawal phase, which is the 
phase when gastroenterologists typically perform polypectomy. However, large polyps 
are removed only during withdrawal as hemorrhage may le d to aborting the procedure if 
removal is attempted during insertion. Because of the major differences, the 2-person 
technique protocol in our study setting is unique and being applied to PCPs, the question 
arises, does this technique enable the quality of PCP-performed colonoscopies to be 
comparable to specialist-performed colonoscopies? Scondly, within specialists/experts, 
does the hands-on 2-person technique improve ADRs? 
Methods 
 The study center, a state-licensed ambulatory surgery center, the South Carolina 
Medical Endoscopy Center (SCMEC) has trained 54 PCPs since 2001  in colonoscopy 
with 140 training procedures supervised by specialists/experts credentialed in screening 
colonoscopy, subsequent colonoscopies by PCPs at the center require adherence to the 
prescribed protocol, with the specialist always avail ble on site for rescue assistance 
(therapeutic assistance to remove advanced adenomas, polyps at difficult locations, 
control bleeding, and/or manage spasms). The Center protocol requires a 2-person 
technique for all PCPs all the time regardless of trained status. Over the study period, 
September 4, 2001 through February 4, 2011, 59 physician  performed colonoscopies, 
the 2-person technique was consistently complied with by 57 physicians (54 PCPs and 3 
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specialists), and 1-person technique was used by 2 non PCPs (one colorectal surgeon and 
one general surgeon), PCPs are defined as those with family medicine, internal medicine, 




Figure 4-1: Study sample selection flowchart 
The innovative 2-person technique protocol requires an endoscopy technician to 
advance the colonoscope while the performing physician manipulates the scope tip for 
polyp search and removal. This method has the additional advantage of avoiding missing 
polyps due to physician's motor fatigue particularly of the left or non-dominant hand. It 
confers the dexterity of two “right” hands (of the two participants) for polyp search and 
removal, and further, ensures more persons watching t e video screen for polyps. The 
study center has used propofol sedation since April 1, 2006 instead of the conventional 
midazolam-meperidine (MM) combination sedation. 2-person technique will be 
examined for its effect on the quality of screening colonoscopies. Additional protocol 
features followed in all 2-person technique procedur s are: a) gradual insertion and 
withdrawal for polyp search and removal to maximize coverage of the colonic mucosal 
surface, b) at least 3 persons watching the video screen. 
20,912 patients between September 4, 2001 and February 4, 2011 
20,570 patients with 
initial colonoscopy 30-
89 years 
30 excludes dues to prior 
history of colon/rectum 
resection 20,540 study 
15,203 patients with 
2-person technique 
4,773 patients with 2-
person technique 
604 patients with 1-
person technique 
342 <30 years & ≥90 
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 The study hypotheses is that screening colonoscopy quality among the 2-person 
protocol group is better than among solo technique protocol group. Our dependent 
variables of interest representing procedure quality re following: likelihood of polyp 
detection (Yes vs. No), likelihood of adenoma detection (Yes vs. No), the likelihood of 
advanced neoplasms detection (Yes vs. No), likelihood f additional polyps detected in 
subjects (0, 1, 2+), likelihood of additional adenomas detected in subjects (0, 1, 2+), 
likelihood of detecting small polyps (No polyp, Small (≤5mm), Medium (6-9mm), Large 
(10+mm)), likelihood of detecting right-sided polyp (polyp location in the cecum, 
ascending colon, hepatic flexure, or transverse colon proximal to the splenic flexure; No 
polyp, Left only, At least one right polyp) , and the procedure time. 
 Our statistical analyses must address non-independence of data due to clustering 
of patients within physician. We expect physician effects to be similar within their patient 
group (for example, each physician’s dexterity of hand movements) but no systematic 
distribution of physician effects across physicians. Therefore, we use generalized 
estimating equations (GEE) modeling. This method assumes a specific correlation 
structure of the repeated measures data within physician, in this case, an exchangeable 
correlation structure.  This structure assumes that any two observations from different 
physicians are uncorrelated, and any two observations fr m the same physician are 
correlated at the same value (no matter within which physician the observations arise). 
GEE was used because it accommodates within-physician correlation without focusing 
attention on that aspect of the data analysis. The within physician correlation is treated as 
an ancillary problem for which to be accounted but is not of profound interest.  When 
using the exchangeable correlation structure for a linear model, the regression parameters 
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of the GEE are algebraically equivalent to the associati n among patients within a 
physician panel.  The same is not quite true for inference of regression parameters from 
the logistic GEE and logistic random effect models. GEE was determined to be the 
preferred modeling tool for these analyses. 
Only the screening colonoscopy procedures of all patients served during this 
period. Subsequent (surveillance) procedures are not included as lesion rates may be 
different at these procedures. Linear GEE regression was used to study the association 
between the procedure time and our variables of interes . Logistic GEE regression was 
applied to test the hypotheses regarding likelihood f any lesion detected. The ordered 
logistic GEE regression was used to test whether the likelihood of finding additional 
polyp(s)/adenoma(s) in a subject, right colon polyp(s), and smaller polyp(s) in a patient 
increased with the use of the 2-person technique. Th  score test was used to verify the 
assumption of ordered logistic regression.  
Results 
 The demographic distribution of the study sample 20,540 patients and by provider 
type is shown in Table 4-1. About 3% of the patients were under 1-person technique 
specialist, 23% of the patients were under 2-person technique specialist, and the 
remaining 74% of the patients were using 2-person technique PCP. Female (53%) and 
Blacks (51%) were slightly preponderant in the study cohort, and 7,772 (37.84%) patients 




Table 4-1: Demographic and procedure characteristics of the study sample 
 No. patients 
n (%) 
Cecum intubation rate (% of  cases) 96.48% 
Protocol type 
1-person technique specialist 604 (2.94) 
2-person technique specialist 4,733 (23.04) 
2-person technique PCP 15,203 (74.02) 
Patient age 
   <50 years 3,792(18.46) 
   50-59 years 9,138(44.49) 
   60-69 years 5,066(24.66) 
   70-89 years 2,544(12.39) 
Patient gender* 
   Male 9,390(45.72) 
   Female 11,054(53.82) 
Patient Race* 
   Whites 9,139(44.49) 
   Blacks 10,623(51.72) 
   Other 682(3.32) 
Number of polyp found**  
   0 7,772 (37.84) 
   1 6,383 (31.08) 
   2+ 6,268 (30.52) 
Polyp size† 
No polyps 7,772 (37.84) 
Small (≦5mm) 11,727 (57.09) 
Medium (6-9mm) 591 (2.88) 
Large (10+mm) 377 (1.84) 
Polyp anatomic location† 
No polyps 7,772 (37.84) 
Left colon 6,387 (31.10) 
Right colon 6,273 (30.54) 
*  Total of 96 patients missing information on gendr and race. 
**Total of 117 patients with missing information on number of polyps. 




Table 4-2 shows the sample distribution by quality indicators. The PDR and the 
mean number of polyps detected per subject (MNP) for solo performing specialists is 
lower with PDR: 46.7% and MNP: 0.74 compared to 2-person technique specialists 
63.8% and 1.23, and 2-person technique PCPs 62.3% and 1.18, respectively. Adenoma 
detection for the 3 groups mostly mirrors the polyp detection pattern, being 23.7%, 
30.6%, and 31.8% rates for the respective groups, and MNA 0.34, 0.49, and 0.52 
respectively. Mean procedure time is shortest in the 1-person technique group (19.68 
minutes) higher for 2-person technique specialists (24.78 minutes), and highest for 2-
person technique PCP (26.21 minutes). Breaking down t  procedures with polyps and 
without polyps found, the pattern of procedure time differences are sustained. Compared 
to solo performers (38.74%), the 2-person technique groups found small, ≤5mm polyps in 
larger proportions of patients (PCP: 57.23%, specialist: 58.99%). Similarly, solo 
performance specialists have lower proportion right colon polyp detected (19.04%) 




Table 4-2: Indicators of colonoscopy quality by procedure protocol 










mean / n(%) mean / n(%) mean / n(%) 
 No. of performing physicians 2 3 54  
 Cecum intubation rate (% of 
cases) 
87.91% 93.24% 97.83% P<.0001 
 Lesion detection rates  
    Polyp detection rate (% of 
cases)* 
46.69 63.81 62.26 P<.0001 
    Number of polyps detected 
per subject (mean, SD)* 
0.74±1.02 1.23±1.39 1.18±1.36 P<.0001 
    Adenoma detection rate (% 
of cases)* 
23.68 30.55 31.78 P<.0001 
    Number of adenomas 
detected per subject (mean, 
SD)* 
0.34±0.74 0.49±0.90 0.52±0.95 P<.0001 
    Advanced neoplasms (% of 
cases)* 
6.79 6.44 6.85 P=.017 
 Procedure duration  
 All colonoscopies     
    Total procedure time 
(min)* 
19.68±8.74 24.78±22.56 26.21±12.13 P<.0001 
 Colonoscopies with no polyp 
found 
    
    Total procedure time 
(min)* 
17.58±6.57 21.66±12.74 22.02±10.24 P<.0001 
 Colonoscopies with polyp(s) 
found 
    
    Total procedure time 
(min)* 
21.97±10.14 26.23±25.75 28.67±12.47 P<.0001 
Polyp size*† P<.0001 
No polyps 53.31 36.19 37.74  
Small (≦ 5 mm) 38.74 58.99 57.23 
Medium (6 – 9 mm) 3.64 2.45 2.98 
Large (10+ mm) 2.98 2.09 1.71 
Polyp anatomic location*† P<.0001 
No polyps 53.31 36.19 37.74  
Left colon 27.65 32.45 30.81 
Right colon 19.04 31.35 30.74 




Table 4-3 and Table 4-4 present multiple regression analyses of the associations 
between technique and the variables of interest. The adjusted procedure time is longest 
for 2-person technique PCPs. Compared to 2-person technique PCPs, 2-person technique 
specialists take an average of 1.01 minutes (p=.184) less, while 1-person technique 
specialists took 3.77 minutes (p<.0001) less time for the procedure, controlling for other 
factors. The adjusted procedure time was longer for older patients (60 – 69 years: 2.06 
mins, p<.0001; 70 – 89 years: 2.93 minus, p<.0001) compared to <50 years. Females had 
longer procedure time (1.11 mins, p<.0001), and if the procedure was a PCP training 
procedure (≤140procedures), it was longer (3.93 mins, p<.0001), as also for each 
additional polyp found (3.16 mins, p<.0001). 
 The likelihood of polyp detection was highest for 2-person technique specialist 
procedures (adjusted OR=1.39) compared to 2-person tech ique PCPs. The 1-person 
technique specialists had 79% less likelihood of detecting a polyp(s) than 2-person 
technique PCPs (adjusted OR=0.56). The effect is sustained for the adenoma yield. 
Compared to 2-person technique PCPs, solo technique specialists were 37% less likely to 
chance in detecting adenoma(s) (adjusted OR: 0.73, p=.005). Specialists using the 2-
person technique have a significantly higher likelihood of detecting adenoma(s) (adjusted 
OR: 1.23, p<.0001). For advanced neoplasm(s), there was no difference between solo 
performing specialists and 2-person technique PCPs (adjusted OR: 1.05, p=.811). But 2-
person technique specialists were slightly more likly to find an advanced neoplasm(s) 
(adjusted OR: 1.14, p=.008). 
 The likelihood of finding a polyp or an additional polyp (given the first polyp) for 
2-person technique PCP is 85% higher relative to 1-person technique specialist (adjusted 
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OR 0.54, 95%CI: 0.36, 0.80). Within specialists, 2-person technique specialists were 
much more likely to find an additional polyp than 1-person technique specialists 
(adjusted OR: 2.48). The adjusted OR for 2-person technique specialists vs. 2-person 
technique PCPs was 1.34 (95%CI: 1.16, 1.54). This pattern was sustained for the 
likelihood of finding each additional adenoma, and within specialists, 2-person technique 
was significantly more likely to be associated with f nding each additional adenoma than 
relative to solo specialist performance (adjusted OR: 1.73). 
 Because right-sided colon polyps are more likely to be missed (Bressler 2004, 
Hewett 2011), polyp anatomic location was modeled. The likelihood of finding right 
colon polyp(s) by solo performing specialists was 82% lower than 2-person technique 
PCPs (OR: 0.55 for 1-person technique specialists). Similar to the findings on other 
indicators, 2-person technique specialists were significantly more likely to detect a right 
colon polyp than solo performing specialists (estima ed OR: 2.42).  
The likelihood of finding small polyp(s) mirrors the pattern of quality indicators 
described above. Solo technique specialists were significantly less likely to find a small 
(≤5mm) polyps than 2-person PCPs (adjusted OR: 0.52, 95%CI: 0.36, 0.77) and 2-person 
technique specialists were the most likely to find i creasingly smaller polyp(s) (adjusted 
OR: 1.36, 95%CI: 1.18, 1.56). We did not model cecum intubation rate as a quality 
indicator because the rate was 96.48% for the sample, and 93.24%, 97.83% and 87.91% 





Table 4-3: Adjusted estimates of colonoscopy performance and outcome quality 
indicators by protocol type*** 









(logistic GEE) † 
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finding an advanced 
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(logistic GEE) † 













0 0 1.00 1.00 1.00 1.00 1.00 1.00 
Patient age 
<50 years 0 0 1.00 1.00 1.00 1.00 1.00 1.00 
50-59 years 0.52 P=.166 1.33 1.21,1.47 1.51 1.35,1.68 1.31 1.08,1.60 
60-69 years 2.06 P<.0001 1.61 1.48,1.75 2.17 1.97,2.38 1.81 1.54,2.13 
70-89 years 2.93 P<.0001 1.83 1.60,2.09 3.02 2.69,3.38 2.17 1.75,2.70 
Patient gender** 
Male 0 0 1.00 1.00 1.00 1.00 1.00 1.00 
Female 1.11 P<.0001 0.75 0.70,0.80 0.64 0.60,0.68 0.65 0.57,0.74 
Patient race** 
Whites 0 0 1.00 1.00 1.00 1.00 1.00 1.00 
Blacks -0.86 P=.082 0.90 0.80,1.01 0.88 0.81,0.97 1.03 0.90,1.17 
Other 0.65 P=.202 0.89 0.73,1.10 0.84 0.69,1.01 0.79 0.55,1.15 
Was this a PCP training procedure? (≤140th procedure for the PCP) 
Yes 0 0 1.00 1.00 1.00 1.00 1.00 1.00 
No -3.93 P<.0001 0.92 0.80,1.05 0.90 0.81,0.99 0.88 0.75,1.02 
Number of 
polyps found 
3.16 P<.0001 - - - - - - 
** Total of 96 patients was missing information on gender and race and excluded from analysis. 
*** Models controlled for sedation type and bowel pre aration status. 




Table 4-4: Adjusted estimates of colonoscopy performance and outcome quality 
indicators by protocol type* 
Dependent variables (colonoscopy quality indicators) 
































1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
Patient age 
<50 years 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
50-59 years 1.33 1.22,1.45 1.52 1.37,1.69 1.38 1.26,1.51 1.31 1.20,1.44 
60-69 years 1.68 1.55,1.81 2.26 2.06,2.48 1.79 1.67,1.92 1.55 1.43,1.68 
70-89 years 1.87 1.66,2.10 3.15 2.82,3.51 2.20 1.97,2.46 1.72 1.51,1.95 
Patient gender** 
Male 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
Female 0.73 0.68,0.78 0.62 0.59,0.66 0.72 0.68,0.77 0.78 0.72,0.83 
Patient race** 
Whites 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
Blacks 0.87 0.78,0.97 0.89 0.81,0.97 0.92 0.83,1.02 0.89 0.79,1.00 
Other 0.85 0.70,1.02 0.84 0.69,1.02 0.85 0.71,1.02 0.93 0.76,1.13 
Was this a PCP training procedure? (≤140th procedure for the PCP) 
Yes 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
No 0.92 0.80,1.06 0.89 0.81,0.99 0.93 0.81,1.05 0.93 0.81,1.07 
* The model controlling for sedation type and bowel preparation. 
** Total of 96 patients missing information on gendr and race. 
† Categories modeled are 0, 1, 2+. 
†† Categories modeled are “No polyp”, “Left only”, “at least one Right polyp”. 





This study finds that an innovation of a hands-on 2-person technique is highly 
associated with superior colonoscopy performance and lesion detection outcomes, and 
that by every discriminating measure, the results wi h the 2-person technique are 
superior, and consistent across measures. The polypyield is much higher with 2-person 
technique PCPs than with 1-person technique specialists, which is by far the most 
widespread protocol in routine screening colonoscopies. Consistent with the literature of 
high competent performance by trained family physicians (Edwards 2004). The effect 
remains significant even when considering adenoma yields and advanced neoplasms 
yields, which indicates that PCPs are able to distinguish adenomas from normal tissue 
polyps on a similar scale as specialists.  
With the help of another element of this study center’s innovative protocol, which 
requires the polyp search and removal in both ways in and out and the gradual spiral 
withdrawal, chance of missing the polyps is proposed to be lower. Because the routine 
protocol performs polypectomy when withdrawing the colonoscope even if polyps were 
detected in insertion period, this might highly missed the polyps because most of the 
time, physicians cannot find the polyps after coming back due to the distortion of the 
colon or mistakenly locate the polyps in memory. Polyp and adenoma detections are 
consistently higher in 2-person technique groups, with regard to the number of 
polyps/adenomas detected in a patient, the 2-person tech ique groups still have higher 
chance of detecting more polyps/adenomas. This tells us that 2-person technique protocol 
is not only superior in detecting a/an polyp/adenoma, but also trying to catch any 
polyps/adenomas to make screening colonoscopy more ben ficial in colorectal cancer 
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prevention to the patients. Regarding to the polyp anatomic location, a constant relation 
was observed, 2-person technique groups (PCPs: 1.82, specialists: 2.42, respectively) are 
about 2 times more likely to detect right colon poly s than 1-person technique specialist. 
Therefore, we are confident to state that 2-person technique protocol offers physicians to 
perform a thorough colon inspection and this is evenly improved both in the left and right 
colon. No specific segment of colon was favored. 
When comparing among specialists, those under 2-person technique protocol are 
consistently showing about 2-fold yields than those under 1-person technique protocol 
with regard to the quality indicators we studied. The 2-person technique protocol plays an 
important role in improving the colon clearance even among specialists by providing an 
additional person with hands-on assistance in manipulating the colonoscope to convey 
two dominant hands for errors caused by motor fatigue (Rogart 2008, Sanaka 2009, 
Buchner 2011) and more persons watching on the video screens for polyp search to 
reduce vision errors (Aslanian 2013). These elements of 2-person technique protocol 
render the warranty of a thorough colon inspection, s  that the missed chance reduces 
with potential colorectal cancer protection increases. 
This study suggests that the 2-person technique by PCPs with onsite specialist 
support may be a solution to the insufficient colonscopy capacity which stands in the 
way of realizing the CRC prevention benefits of colonoscopy (Seeff 2006). PCPs 
performing colonoscopy has been debated due to the lack of specialty training. The study 
center provides PCPs a training program since 2001 and the unique element of 2-person 
technique protocol improves the colonoscopy quality in general, the 2-person technique 
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for PCPs rebuts the controversy of the inferiority of PCP colonoscopy quality in the 




Manuscript #2: Does sedation type (midazolam-meperid ne vs. Propofol) affect 
screening colonoscopy performance quality and polyp detection outcomes? 
Abstract 
Background: Over the past decade the age-adjusted colorectal cancer (CRC) incidence 
has significantly decreased. Most CRC cases and deaths c n potentially be prevented by 
colonoscopy screening which enables both primary prevention through removal of pre-
cancerous polyps and secondary prevention through early detection of cancer cases. 
However the at-risk population’s uptake of screening colonoscopy has been less than 
optimal. One reason could be public perceptions of colonoscopy as an invasive and 
potentially painful procedure, particularly concerns about partially or unsedated 
colonoscopy. Offering deep sedation which is documented to provide a well anesthetized 
procedure experience and to alleviate patient fear of comfort may increase the 
acceptability of colonoscopy. There is little systematic documentation of how sedation 
type affects colonoscopy performance quality and lesion detection outcomes.  It is 
important to systematically study whether deep sedation independently improves 
colonoscopy performance quality in ways that signifcantly impacts its CRC prevention 
potential.  
Objectives: This study examines the effect of propofol sedation relative to midazolam-
meperidine (MM) sedation in a setting where a high-performance, polyp detection-
maximizing colonoscopy protocol has been in place for 10 years. 
Methods: Retrospective cohort study of all screening colonoscopies done at a state-
licensed ambulatory surgery endoscopy center in South Carolina from September 4, 2001 
and February 4, 2011. Propofol sedation in lieu of MM sedation was implemented since 
118 
 
April 1, 2006. Because all other clinical protocol and patient navigation elements were 
consistently implemented, these series enable the study of the independent associations of 
propofol sedation with procedure quality and lesion detection outcomes. Patient is the 
unit of analysis. The dependent variables representing procedure quality and outcomes 
are procedure time and lesion detection captured at several levels of difficulty. The key 
independent variable of interest is sedation type (propofol or MM). 
Our study hypothesizes that propofol sedation is more likely to be associated with 
finding a polyp/adenoma relative to no polyp/adenoma, and the same odds applies to 
finding each additional polyp/adenoma Bowel preparation status significantly affects 
procedure completion and therefore lesion detection rates. Therefore in assessing the 
effectiveness of sedation type it is essential to adjust for bowel preparation status.  
Results: Of total 20,540 study-eligible patients provided a screening colonoscopy from 
September 4, 2001 through February 4, 2011, 11,266 patients were sedated with MM 
(54.85%, all pre-April 1, 2006), and 9,274 patients with propofol (45.15%, from April 1, 
2006). The polyp detection rate was higher in propof l-sedated patients (63.49%) 
compared to MM (61.07%, p<.05), as was the mean number of polyps found per patient 
(1.33 vs. 1.06, p<.0001), with similar differences in most lesion detection indicators. 
Mean procedure time was shorter with propofol sedation (25.08 vs. 26.25 min for MM). 
Propofol sedation was associated with slightly higher odds of finding an advanced 
neoplasm (adjusted OR: 1.14, 95%CI: 1.01, 1.29) and with finding an additional polyp 
(adjusted OR: 1.25, 95%CI: 1.07, 1.46) compared to MM sedation. 
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Conclusions: Propofol sedation may contribute marginally to improved colonoscopy 
quality, although quality improvement efforts may be better rewarded if focused on 
measures to improve patient bowel preparation including patient navigation. 
Introduction  
 Over the past decade the age-adjusted colorectal cancer (CRC) incidence 
decreased from 51.8/100,000 in 1999 to 44.7/100,000 in 2 09, and the age-adjusted 
decreased from 20.5/100,000 to 16.9/100,000 (SEER 2013). Despite these reductions, 
CRC remains a significant public health problem, affecting over 5% of Americans over 
their lifetime (U.S. Cancer Statistics Working Group 2013) and killing 50% more 
Americans than motor vehicle accidents (NHTSA 2012). Colonoscopy is recommended 
as the preferred screening method because it enables primary prevention through removal 
of pre-cancerous polyps (Rex 2000, Davila 2006, Rex2009). However the uptake of 
colonoscopy by at-risk population (aged 50 years or older, 40 years for those with a 
family history of CRC) has been less than optimal, being 13.4% in 2005 and 36.4% in 
2010 (calculated from the National Health Interview Survey 2005 and 2010 data).  
 One reason for low uptake of colonoscopy could be perceptions of colonoscopy as 
an invasive and potentially painful procedure, particularly concerns about partially 
sedated or unsedated colonoscopy, limiting CRC prevention efforts (Rex & Khalfan 
2005, Sipe, Rex, Latinovich 2002). Offering deep sedation which is documented to 
provide a well anesthetized procedure experience and to alleviate patient fear of 
discomfort (Sipe, Rex, Latinovich 2002, Heuss 2004) may increase the acceptability of 
colonoscopy. However deep sedation entails additional costs, notably personnel cost 
(nurse anesthetists).  Payers are more likely to cover costs that facilitate better quality and 
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colonic clearance of polyps enhancing the CRC prevention impact of colonoscopies, 
which in turn would reduce future treatment costs from the CRC cases prevented.  
There is little systematic documentation of how sedation type affects colonoscopy 
performance quality and polyp detection outcomes. The available evidence is mixed, 
based on retrospective studies of procedure series that were not standardized for other 
protocol elements that greatly impact the reported outcomes. Three studies of important 
quality indicators, procedure completion rate (cecal intubation), and adenoma detection 
rate showed positive associations with deeper sedation relative to mild sedation (Chelazzi 
2009, Radaelli 2008, Wang 2010), while three others showed no significant associations 
(Paspatis 2011, Rex 2012, Metwally 2011, Bannert 2012). Chelazzi et al (2009) reported 
100% procedure completion rate under propofol sedation compared to 91.1% for non-
sedated procedures (p<.05), with 1.5 minutes shorter ins rtion time the propofol group (9 
minutes) than the non-sedated group (p=.0086). Radaelli et al reported the highest odds 
of cecal intubation with propofol sedation (OR =2.36 relative to the non-sedated group), 
followed by benzodiazepine-opiate (OR =2.13), and benzodiazepine alone (OR =1.46). 
They also reported a similar pattern of increasing polyp detection with increasing 
sedation (highest likelihood of detection with propofol sedation (OR=1.32) followed by 
benzodiazepines (OR =1.12). A study of midazolam and pethidine used in specified doses 
to produce moderate (MS) and deep sedation (DS) found no significant difference in the 
polyp detection rate (MS: 61.5%, DS: 63.6%), adenoma detection rate (MS: 59.5%, DS: 
60.4%), and right colon polyp detection rate (MS: 34.4%, DS: 36.8%) (Paspatis 2011). 
Another study found no difference in adenoma detection rates of procedures sedated by 
propofol vs. midazolam/fentanyl (Metwally 2011). A retrospective cohort study across 72 
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facilities reported a somewhat higher polyp detection rate with moderate sedation than 
with deep sedation (37.7% vs. 34.1%, p<.0001) but lower advanced adenoma detection 
(6% vs. 7.2%, p=.01), the latter effect being greater in facilities where deep sedation 
procedures exceeded 10% of their respective total procedures (7.5% vs. 5.7%, p=.003) 
(Wang 2010). None of the studies reported on propofol sedation compared to the most 
commonly used sedation type, midazolam-meperidine. 
 The evidence on procedure completion and adenoma detection rates by sedation 
type/level remains mixed. However, the evidence is clear regarding patient satisfaction 
with pain control. All propofol-sedated patients reported no pain (102 out of 102 
patients), compared to 17 out of 23 persons in the midazolam group, and 11 out of 22 in 
the no sedation group (Gasparovic 2003). 
 The above evidence suggests that deep sedation by propofol may be time saving 
and it achieves full pain control compared to other sedatives. The mixed results for other 
colonoscopy quality indicators are reasonably attribu able to the documented widely 
variable colonoscopy protocols and performance preferences of endoscopists (Barclay 
2006, Rex 2001). It is important to systematically study whether deep sedation 
independently improves colonoscopy performance quality in ways that significantly 
impacts its CRC prevention potential.  This is a key issue of interest to medical 
professionals and payers. This study addresses this need by examining the effect of 
propofol sedation relative to midazolam-meperidine (MM) sedation in a setting where a 
high-performance, polyp detection-maximizing colonosc py protocol has been in place 
for 10 years. (The details of these clinical protocl elements are described in a previous 
paper.) All providers either adhered to the colonoscopy protocol (57 of 59) or were 
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identified as non-adherent, and uniform patient navigation to reinforce bowel preparation 
instructions was provided to all patients. The center has maintained rigorous 
documentation of procedures and outcomes since 2001 enabling a systematic study of the 
independent associations of propofol sedation (instituted for all center procedures since 
April 1 2006) with procedure quality and lesion detection outcomes, by comparing 
propofol sedated procedures with MM procedures (pre-April 1, 2006).  
Methods 
  This is a retrospective cohort study of all screening colonoscopies done at a state-
licensed ambulatory surgery endoscopy center in South Carolina from September 4, 2001 
and February 4, 2011. Propofol sedation in lieu of MM sedation was implemented since 
April 1, 2006. Because all other clinical protocol and patient navigation elements were 
consistently implemented, these series enable the study of the independent associations of 
propofol sedation with procedure quality and lesion detection outcomes. Patient is the 
unit of analysis of. Of total 20,912 patients, 20,540 patients were study-eligible after 
excluding 342 patients aged less than 30 years and over 89 years, and 30 patients with a 





Figure 4-2: Sample selection flowchart 
The dependent variables representing procedure quality and outcomes are as 
follows: likelihood of finding a polyp (Yes vs. No), likelihood of finding an adenoma 
(Yes vs. No), likelihood of finding an advanced neoplasm (Yes vs. No), likelihood of 
finding each additional polyp (0, 1, 2+), likelihood f finding each additional adenoma (0, 
1, 2+), likelihood of finding a right-sided polyp (no polyp, left only, at least one right-
sided polyp found), and likelihood of finding a smaller polyp (no polyp, at least one 
small(≦5mm) polyp found, at least one medium (6-9mm) found, at least one 
large(10+mm) polyp found). The key independent variable of interest is sedation type 
(propofol or MM) and the control variables are bowel preparation status, patient age, race, 
gender, was this a PCP training procedure, and the number of polyps found. 
26,523 procedures as 
of February 4, 2011 
20,912 initial procedures 
20,570 patients with initial 
colonoscopy 30-89 years 
30 excludes dues to prior history 
of colon/rectum resection 
20,540 study eligible 
9,274 patients with 
Propofol sedation 
11,266 patients with Midazolam-
meperdine sedation 
342 <30 years & ≥90 years 
5,611 2nd and later procedures 
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Because patients are nested within physician and are likely to experience a unique 
physician level effect, we conducted multilevel modeling. Patients within a physician 
panel are considered to have an exchangeable correlation, and any two patients served by 
different physicians are considered uncorrelated. Generalized estimating equation (GEE) 
is used to test the associations of interest. To model dichotomous dependent variables, 
such as the likelihood of detecting a polyp/adenoma/advanced adenoma in subjects, 
logistic GEE regression model was used. For ordinal variables, such as the likelihood of 
finding each additional polyp/adenoma, the likelihood of finding at least one right colon 
polyp, likelihood of finding increasingly smaller polyps, and the likelihood of having a 
shorter procedure duration an ordered logistic GEE regression model was used. The score 
test in SAS applied to verify the validity of this a sumption. Our study hypothesizes that 
propofol sedation is more likely to be associated with finding a polyp/adenoma relative to 
no polyp/adenoma, and the same odds applies to finding an additional polyp/adenoma 
Bowel preparation status significantly affects procedure completion and therefore lesion 
detection rates. Radaelli showed 40% lower odds of procedure completion with good 
bowel preparation vs. excellent (Radaelli 2008). Therefore in assessing the effectiveness 
of sedation type it is essential to adjust for bowel pr paration status.   
Results 
 Of total 20,540 study eligible patients (provided screening colonoscopies from 
September 4, 2001 through February 4, 2011), all pre-April 1 2006 patients were sedated 
with MM, 11,266 (54.85%), and from April 1, 2006 with propofol, 9,274 patients 
(45.15%). Table 4-5 shows the sample distribution by demographic and procedure 
characteristics. The majority were aged 50 – 59 years (44.5%), female (53.82%), and 
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Black (51.72%). Polyps were detected in 61.6% of patients, and majority of patients had 
only small polyps (91.8% ≤5mm). Among those with polyps, half of the patients had at 




Table 4-5: Demographic and procedure characteristics of the study sample 
 No. of patients 
n (%) 
Sedation type 
M-M 11,266 (54.85) 
Propofol 9,274 (45.15) 
Good bowel preparation† 
Yes 18,613 (90.62) 
No 1,561 (7.60) 
Patient age 
   <50 years 3,792(18.46) 
   50-59 years 9,138(44.49) 
   60-69 years 5,066(24.66) 
   70-89 years 2,544(12.39) 
Patient gender* 
   Male 9,390(45.72) 
   Female 11,054(53.82) 
Patient Race* 
   Whites 9,139(44.49) 
   Blacks 10,623(51.72) 
   Other 682(3.32) 
Number of polyp found**  
   0 7,772 (37.84) 
   1 6,383 (31.08) 
   2+ 6,268 (30.52) 
Polyp size† 
No polyps 7,772 (37.84) 
Small (≦5mm) 11,727 (57.09) 
Medium (6-9mm) 591 (2.88) 
Large (10+mm) 377 (1.84) 
Polyp anatomic location†† 
No polyps 7,772 (37.84) 
Left colon 6,387 (31.10) 
Right colon 6,273 (30.54) 
*  Total of 96 patients missing information on gendr and race. 
**Total of 117 patients with missing information on number of polyps. 
† 366 patients missed sedation type in combination with bowel preparation information. 
†† 73 patients had missing polyp size information, 108 patients were missing information on 
polyp anatomic location. 
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Table 4-6 presents the colonoscopy performance quality and lesion outcomes 
distributed by sedation type. The polyp detection rate was higher in propofol-sedated 
patients (63.49%) compared to MM (61.07%) (p<.05), as was the mean number of polyps 
found per patient (1.33 vs. 1.06) (p<.0001). The patterns of differences in adenoma 
detection and advanced neoplasm detection also follow the above pattern (propofol: 
31.73%, MM: 30.86% for adenomas and 7.12% vs. 6.46% for advanced neoplasms, all 
p<.05), as also the mean number of adenomas found per patient screened (0.53 vs. 0.48), 
the detection rate for small polyps (58.01% vs. 56.34%), and for any right colon polyp 
(31.3% vs.29.9%). The mean procedure time is shorter wi h propofol sedation (25.08 vs. 
26.25 min for MM), both when polyps were detected (27.51 vs. 28.33 min.) and no 








mean / n(%) mean / n(%) 
 No. of patients 11,266(54.85) 9,274(45.15)  
Cecum intubation rate (% of cases) 10,719 (95.14) 9,098 (98.10) P<.0001
Good bowel preparation P<.0001
Yes 10,112 (89.76) 8,501 (91.66)  
No 847 (7.52) 714 (7.70) 
 Lesion detection rates  
    Polyp detection rate (% of cases)* 61.07 63.49 P=.0004
    Number of polyps detected per 
subject(mean, SD)** 
1.06±1.19 1.33±1.52 P<.0001
    Adenoma detection rate (% of cases)** 30.86 31.7  P=.001 
    Number of adenomas detected per 
subject(mean, SD)** 
0.48±0.88 0.53±1.00 P<.0001
    Advanced neoplasms (% of cases)**  6.46 7.12 P=.0004
 Procedure duration  
 All colonoscopies    
    Total procedure time (min)** 26.25±17.52 25.08±11.48 P<.0001
 Colonoscopies with no polyp found    
    Total procedure time (min)** 22.66±11.62 20.69±9.33 P<.0001
 Colonoscopies with polyp(s) found    
    Total procedure time (min)** 28.33±19.86 27.51±1 .84 P<.0001
Polyp size**† P=.003 
No polyps 4,386 (38.93) 3,386 (36.51)  
Small polyp with or without medium or large 
polyp(≦5mm) 
6,347 (56.34) 5,380 (58.01) 
Medium with/without large polyp (6-9mm), no 
small polyp 
306 (2.72) 285 (3.07) 
Large polyp only (≥ 10mm) 189 (1.68) 188 (2.03) 
Polyp anatomic location**† P<.0001
No polyps 4,386 (38.93) 3,386 (36.51)  
Left colon only 3,402 (30.20) 2,985 (32.19) 
Right colon (with or without left colon polyp) 3,370 (29.91) 2,903 (31.30) 
† 73 patients had missing polyp size information, 108 patients were missing information on polyp 
anatomic location. 
 
Table 4-7 and 4-8 show the associations between sedation type and colonoscopy 
quality indicators adjusting for patient demographics and other procedure-related factors. 
The adjusted procedure time is showed somewhat longer duration with MM sedation than 
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propofol sedation although it did not attain statisical significance (0.97 min longer, 
p=.093). Propofol sedation was associated with slightly higher odds of finding advanced 
neoplasm(s) (adjusted OR: 1.14, 95%CI: 1.01, 1.29) and slightly higher odds of finding 
an additional polyp (adjusted OR: 1.25, 95%CI: 1.07, 1.46) compared to MM sedation. 
The associations were not statistically significant for the likelihood of finding at least one 
polyp and finding an adenoma (adjusted ORs: 1.11 and 1.08, respectively). Similarly the 
likelihood of finding at least one right-sided polyp(s) was not significant (adjusted OR: 
1.10), as was the likelihood of finding increasingly smaller polyp(s) (adjusted OR: 1.08) 
because all confidence intervals spanned 1.0. 
Unlike the sedation type, bowel preparation status is showing consistently high 
and statistically significant associations. Good bowel preparation is significantly 
associated with a shorter procedure durations (3.46 min, p<.0001). Better bowel 
preparation was also associated with higher likelihood of finding polyp(s) (1.43, 
p<.0001), finding adenoma(s) (1.18, p=.005), finding a  additional polyp (1.38, 
p<.0001), finding at least one right-sided polyp (1.31, p<.0001) and finding increasingly 
smaller polyp(s) (1.42, p<.0001). The likelihood of finding advanced neoplasm(s) was 
not associated with bowel preparation status with the exception of finding an additional 
adenoma when the bowel preparation status was good vs. poor (adjusted OR: 1.16, 




Table 4-7: Adjusted estimates of colonoscopy performance and outcome quality 
indicators by sedation type* 
* Model controlled for protocol type and whether bowel preparation is “Good” or “No Good”. 
** Total of 96 patients was missing information on gender and race and excluded from analysis. 
† Categories modeled are “No” and “Yes”. 
  









(logistic GEE )† 
Likelihood of finding 
advanced 
neoplasm(s) 
(logistic GEE )† 
β p-value OR 95%CI OR 95%CI OR 95%CI 
Sedation type 
M-M 0 0 1.00 1.00 1.00 1.00 1.00 1.00 
Propofol -0.97 P=.093 1.11 0.97,1.26 1.08 0.98,1.19 1.14 1.01,1.29 
Good bowel preparation 
Yes -3.46 P<.0001 1.43 1.29,1.60 1.18 1.05,1.33 1.10 0.89,1.35 
No 0 0 1.00 1.00 1.00 1.00 1.00 1.00 
Patient age 
<50 years 0 0 1.00 1.00 1.00 1.00 1.00 1.00 
50-59 years 0.52 P=.166 1.33 1.21,1.47 1.51 1.35,1.68 1.31 1.08,1.60 
60-69 years 2.06 P<.0001 1.61 1.48,1.75 2.17 1.97,2.38 1.81 1.54,2.13 
70-89 years 2.93 P<.0001 1.83 1.60,2.09 3.02 2.69,3.38 2.17 1.75,2.70 
Patient gender** 
Male 0 0 1.00 1.00 1.00 1.00 1.00 1.00 
Female 1.11 P<.0001 0.75 0.70,0.80 0.64 0.60,0.68 0.65 0.57,0.74 
Patient race** 
Whites 0 0 1.00 1.00 1.00 1.00 1.00 1.00 
Blacks -0.86 P=.082 0.90 0.80,1.01 0.88 0.81,0.97 1.03 0.90,1.17 
Other 0.65 P=.2017 0.89 0.73,1.10 0.84 0.69,1.01 0.79 0.55,1.15 
Was this a PCP training procedure? (≤140th procedure for the PCP) 
Yes 0 0 1.00 1.00 1.00 1.00 1.00 1.00 
No -3.93 P<.0001 0.92 0.80,1.05 0.90 0.81,0.99 0.88 0.75,1.02 
Number of 
polyp found 
3.16 P<.0001 - - - - - - 
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Table 4-8: Adjusted estimates of colonoscopy performance and outcome quality 
indicators by sedation type*  
* Model controlled for protocol type and whether bowel preparation is “Good” or “No Good”. 
** Total of 96 patients was missing information on gender and race and excluded from analysis. 
† Categories modeled are 0, 1, 2+. 
†† Categories modeled are “No polyp”, “Left only”, “at least one Right polyp”. 
††† Categories modeled are “No polyp”, “Small”, “Medium”, “Large”. 
 









finding at least 








OR 95%CI OR 95%CI OR 95%CI OR 95%CI 
Sedation type 
M-M 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
Propofol 1.25 1.07,1.46 1.09 0.99,1.20 1.10 0.96,1.26 1.08 0.95,1.23 
Good bowel preparation 
Yes 1.38 1.24,1.52 1.16 1.03,1.30 1.31 1.19,1.45 1.42 1.29,1.57 




1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
50-59 
years 1.33 1.22,1.45 1.52 1.37,1.69 1.38 1.26,1.51 1.31 1.20,1.44 
60-69 
years 1.68 1.55,1.81 2.26 2.06,2.48 1.79 1.67,1.92 1.55 1.43,1.68 
70-89 
years 1.87 1.66,2.10 3.15 2.82,3.51 2.20 1.97,2.46 1.72 1.51,1.95 
Patient gender** 
Male 0 0 0 0 1.00 1.00 1.00 1.00 
Female 0.73 0.68,0.78 0.62 0.59,0.66 0.72 0.68,0.77 0.78 0.72,0.83 
Patient race** 
Whites 0 0 0 0 1.00 1.00 1.00 1.00 
Blacks 0.87 0.78,0.97 0.89 0.81,0.97 0.92 0.83,1.02 0.89 0.79,1.00 
Other 0.85 0.70,1.02 0.84 0.69,1.02 0.85 0.71,1.02 0.93 0.76,1.13 
Was this a PCP training procedure? (≤140th procedure for the PCP) 
Yes 0 0 0 0 1.00 1.00 1.00 1.00 




Propofol sedation has been of interest to gastroenterologists because it enables 
very rapid induction of deep sedation and rapid recov ry. This enables more efficient 
utilization of the endoscopist’s time as well as the additional costs of the associated staff 
and infrastructure while supporting patients’ gradul recovery with MM and other 
sedation types. Additional advantages of propofol that are well-documented are far better 
and reliable pain control and higher patient satisfction.  
A key question however is whether it improves the quality of the procedure in 
terms of achieving pan-colonic polyp clearance, because the additional costs incurred for 
propofol administration may be justifiable to payers if the ultimate clinical outcomes and 
downstream cost reductions to be achieved can be demonstrated. This is the first study to 
evaluate this question using a very large series in an unusual setting where rigorous 
quality assurance mechanisms and documentation are i place, elements of the clinical 
protocol other than sedation type were kept constant across providers (or documented for 
providers not adhering to certain colonoscopy protoc l elements), and a large number of 
providers’ procedures are included in the sample (59 providers).  
We find that while there is a suggestion of a positive association of propofol 
sedation with improved lesion detection and clearance as measured by sensitive 
indicators, the results did not attain statistical significance except in respect of one 
indicator, the advanced adenoma detection rate, and in a reduction in procedure time.  We 
used several uncommon indicators of colonoscopy quality in addition to the standard 
measures reported routinely such as adenoma detection ra es, mean number of adenomas 
per screened patient. These include the likelihood of detecting a small adenoma detection, 
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and of detecting the relatively elusive right colon polyp. Although we found a consistent 
pattern of slightly better detection of lesions with propofol sedation compared to MM 
sedation, the results did not attain statistical significance despite our large sample size. 
Our findings are similar to those of other studies that examined the depth of sedation 
rather than sedation agents used (Paspatis 2011). Our findings may be due to the 
possibility that the study center ensures deep sedation for all patients regardless of 
sedation type.  
An important study finding is the role of bowel prearation status in the detection 
rates of all types of lesions, particularly the more elusive lesions such as smaller 
adenomas and right colon polyps which could be perilous to the patient if left behind. Our 
study validates the findings of Radaelli et al and d s to the literature by extending the 
documented associations to the finer indicators of quality, small adenoma detection, 
likelihood of detecting each additional adenoma, and likelihood of detecting a right colon 
polyp. Missing of right colon polyps at colonoscopy is documented to be widespread and 
thought to be a major driver of a large proportion of colorectal cancers arising despite 
colonoscopy screening. 
In summary, our findings suggest that propofol sedation may contribute 
marginally to improved colonoscopy quality, although quality improvement efforts may 
be better rewarded if focused on measures to improve patient bowel preparation through 
efforts directed at patients for example, through patient navigation. Regarding propofol 
sedation itself, our findings suggest that endoscopi ts’ decisions to adopt propofol 
sedation should be guided more by considerations of patient comfort and satisfaction, as 
well as efficiency of endoscopist time utilization rather than an expectation of improved 
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lesion detection rates. Our study does not provide support for adoption of propofol 
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Appendix A DATA MANAGEMENT PROCESS 
• Preparing and cleaning the data: 
De-identified data on all colonoscopies conducted during September 4, 2001 and 
February 4, 2011 were downloaded from the SCMEC’s administrative and clinical 
datasets for this study. To prepare and clean the data ready for analysis, the data 
collection and management processes are as below: 
V:\ColScope\SCMEC\Data\SASfilz\old stuff\ImportData\ImportData.sas 
Several datasets imported from SCMEC on October 10, 20 7 including physician 
dataset, appointment dataset, billing dataset, and polyp dataset imported to USC system. 
(Import Data. sas) 
V:\ColScope\SCMEC\Data\SASfilz\old stuff\CombineData\2011\CombineData\PCP 
Data.sas 
Physician demographics data was imported from the SCMEC in 2007 including 
ID, name, gender, race, age as of 2007, year of graduation, area of specialty, years of 
experience since graduation as of 2007, is this phyician board certified and the reason 
for exclusion if this physician is not qualified to our study. Total of 64 physicians were 
read in (Rawdat.pcp) and extra 3 physicians (extrapcp) were updated later adding up to 
67 physicians in our original physician dataset (Rawd t.pcp2).
155 
 
V:\ColScope\SCMEC\Data\SASfilz\DA2012\Polyp Data 10- 7-12.sas 
oldraw.polypupdate2 (n=180) 
This is an update patch done in 2008. This file has polypid and the polyp_results 
coded as 1-9 (this was obviously from patient charts). This file contained polyp data 
2001-2002, was originally found no pathology text, but discovered path_results in 
colonoscopy sheet of “Coldata.xls”. “Compress” function was used to return a character 
string with specified characters removed from the original string for operationid and 
polypid. 
Old polyp data was read in from polyps sheet of Coldata.xls covering polyp 
information from 9/1/1999 to 11/1/2007. Remove duplicates due to data download 
(n=16,426) and data entry (n=1). Old polyp data (N=16,427) was merged with the 2008 
update (N=180) after it was cleaned, named as “OldPolyps1 (N=16,607). 
New polyp dataset of 32,726 observations was then read in, this polyp dataset 
covered from 2001 to 2011 (V:\ColScope\SCMEC\Data\Rawdata\2011\polyps 2011.xlsx). 
“ignoredestroyed” and “dysplasia” were reformatted from characters to numeric variables. 
After cleaning up some default setting of the dataset, old polyp data that were missing 
data with info was updated from the new polyp data.  
AllPolyps: Update old polyps (n=16,607) with new polyps (n=32,726). Because 
oldraw.polypupdate2 (n=180) is not contained in newpolyps, the combined AllPolyps has 
32,908. 
Several correction and updating codings were applied afterwards as bellows: 
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1. “Substr” function for taking substrings of matrix elements for “OperationId” to 
“OperId”,  
2. Data value recode – erroneous value due to limitation when importing and 
missing value format recode, 
3. Variable rename, 
4. Dysplasia update coding from pathologytext and path_results matching both by 
OperId/polypno and polypId. 
Apply correction code for missing data and recodes to all polyps (%include 
'V:\ColScope\SCMEC\Data\SASfilz\DA2012\CorrectionUpdateCoding\MissingDataUpd
ates10-10-12.sas';)  
The updates of Summer 2011 for missing value were read in from Access 
worksheet, the datasets were: (Access datasets are at
"V:\ColScope\SCMEC\Data\Rawdata\2011\NewMissingData\SCMEC Missing Data 
updated 09292011\SCMEC Missing Data 1.accdb" and           
DATABASE="V:\ColScope\SCMEC\Data\Rawdata\2011\NewMissingData\SCMEC 
Missing Data updated 09292011\SCMEC Missing Data 2.accdb";) 
1. PolRes for polyp_result update,  
2. PolSize for Polypsize update,  after reading in we manually recoded various 
formats couldn’t be specified due to data entry, 
3. PolQuant for PolypQuantity update,  
4. PolLoc for Polyplocation update,  
5. PolCol for Color update, the “color” variable was renamed to “morphology” 
variable, and a “macro” function for morphology was used to create 
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“PeduncSessile”, “Erythematous”, Flat”, “ Multilobular”, “Violaceous”, and 
“ Serrated” variables. For “ Serrated” variable, text search was additional used on 
pathologytext to fully capture the endoscopist procedure notes, 
6. PolHow for polypectomy update. 
“V:\ColScope\SCMEC\Data\SASfilz\DA2012\CorrectionUpdateCoding\PolypRe
sultsUpdate10-16-12.sas”, this program used pathologytext (hierarchical text search) and 
pathresults (linked by combination of OperID and poly no) and manual review as total of 
4,746 to update to polyp_result. 
Now, we have pathresults, pathologytext and polyp_result variables all for coding 
the results of the polyp, therefore, we incorporated and updated them into “polyp_result” 
variable using the Correction and Update Coding.  
Remove polyps from Minhas Hospital procedures 
After the updating program was applied, we removed Minhas-procedure polyps 
by getting the operationid of the procedures from Rawdat.MinhasHospital dataset. 
(polyps from 34 procedures were removed) (See line 449-461) 
How we produced final product of “Rawdat.finalpolyps2012” of this program 
It was created after categorizing Adenoma, AdvAdenoma SerratedAdenoma, 
HyperPolyp, NormoPolyp, Carcinoid, Carcinoma, and AdvNeoplasm variables using 
polyp_result and dysplasia level. 
V:\ColScope\SCMEC\Data\SASfilz\old 
stuff\CombineData\2011\CombineData\Colonoscopy Data.s s 
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Rawdat.colonoscopy was imported from “coldata.xls” a  colonoscopy procedure 
data from the SCMEC (Rawdat.colonoscopy has 17,790 procedures, 30 duplicated entries 
by SCMEC staff were deleted. Total now is 17,760.)   
The revised colonoscopy dataset is now updated with n=17,773 from 
rawdat.colonupdate (this should be chart review, missing data capture on procedure times 
etc.)  The output as “colonoscopy01” has 17,761 observations. 
This was now updated with missing operation time, intubation and prep status 
data for 227 observations (rawdat.colonupdate2(n=227) ) from  
V:\ColScope\SCMEC\Data\Rawdata\Update7-21-08\ ColonoscopyUpdateN227.xls. This 
update output as “colnoscopytemp” has 17,761 observations. 
Update new procedures May 2008 to Dec 2011 are now updated using 
V:\ColScope\SCMEC\Data\Rawdata\2011\Colonoscopy2011.xlsx (n=9848). 
[colonoscopytemp(17,761) + colonoscopyNew3 (n=9,848) should be = 27,609, obviously 
some duplicates in new dataset, therefore colonoscopy has 27,472.] 
All of the updates were updated to Rawdat.colonoscopy, 
"V:\ColScope\SCMEC\Data\SASfilz\old stuff\Correction coding\CorrectTimes.sas" and 
"V:\ColScope\SCMEC\Data\SASfilz\old stuff\Correction coding\CorrectAge.sas" were 
both brought in for procedure times and age corrections. Procedures prior September 
2001 were output to pre9_2001 (n=808), procedures with missing patientID were output 
to noptid(n=10), and the remaining eligible were output as colnoscopy1temp(n=26,654), 
which is post September 2001 procedure dataset. 
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In Summer of 2011 over 10,000 patient charts review for data collection on 
missed/discrepant patient/procedure information including check on patient date of birth, 
date of procedure, bowel preparation, incomplete reason, procedure time point (time of 
insertion, viewing cecum and withdrawal),and pathology report to verify polyp 
information including polyp size, location, how taken,  and polyp result. Updates were 
stored as Access format as “newmissing1”(n=2,024) and “newmissing2”(n=2,023) from 
“V:\ColScope\SCMEC\Data\Rawdata\2011\NewMissingData\SCMEC Missing Data 
updated 09292011\SCMEC Missing Data 1.accdb” and 
“V:\ColScope\SCMEC\Data\Rawdata\2011\NewMissingData\SCMEC Missing Data 
updated 09292011\SCMEC Missing Data 2.accdb” when two teams were working on-site 
collecting data. After combining and the management of the dataset (e.g., we could not 
find the patientid for the patient chart, and it turns out there were two patientids for one 
patient and we got the old one, the SCMEC helped us to figure out the corresponding 
new patientid for the patient so that we can locate the patient chart for review, therefore 
patientid update was done here and calculated the procedure time as minute per the 
documented timing of start and end of the colonoscopy and timing of viewing cecum, 
patient age calculated using interval function (int) between procedure date and patient 
date of birth), two missing update datasets were output as “allrecentnewupdate”(n=4,047) 
and update into colonoscopy1temp (post September 2001 procedure dataset).  
In colonoscopy2, "V:\ColScope\SCMEC\Data\SASfilz\old stuff\Correction 
coding\CorrectTimes.sas", "V:\ColScope\SCMEC\Data\SASfilz\old stuff\Correction 
coding\CorrectAge.sas", V:\ColScope\SCMEC\Data\SASfilz\old stuff\Correction 
coding\IncompleteReasons.sas", and "V:\ColScope\SCMEC\Data\SASfilz\old 
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stuff\Correction coding\PolypMissing.sas" were brought in for procedure times, age, 
incomplete reasons, and polypmiss (polyp data not found in records-exclude from 
denominator) corrections. 
Text search on “ProcComments” was used here for excluding cancelled 
procedures (n=39) and on “comments” PLUS providerID in (19,36,37,57) for excluding 
Minhas trained procedures (n=34). 
After excluding, procedures in Colonoscopy2(n=26,523), cancandnull(cancelled 
procedures and null, appointment taken not show up, n=55), ColPrepNull(n=2), 
howmany(patientid available chart not traceable, n=1), rawdat.MinhasHospital(n=34) and 
39 cancelled appointments. 
Physician specialty was recoded based on 
“V:\ColScope\SCMEC\Data\Rawdata\PCP\PhysicianList go hrough with Dr Lloyd  5-
03-2012.xlsx”, this file was new update since 2008 that we went through with Dr Lloyd 
of each physician to determine the specialty and the training process and does the 
physician should be included or excluded from our st dy. 
Based on the “PhysicianList go through with Dr Lloyd  5-03-2012.xlsx”, 
physician specialty was categorized here of providerID in (1,64,22,56,59) as specialist, 
PCPCs for the remaining physicians. 
The physician specialty now is correctly classified under “specialist” variable. 
The “ColPCPSeq” variable was created using macro function and patched in 
“colonoscopy2” procedures data and output as “colonoscopy3”. The provider 
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demographics were read in from “rawdat.pcp2” and patched in “colonoscopy3”, output as 
“Colonoscopy4”. 
V:\ColScope\SCMEC\Data\Rawdata\2011\MissingRaceAndGe er 8-19-2011.xlsx 
During August of 2011, a round of data collection on filling in 2645 missing 
patient gender and race after exporting data from the SCMEC (MISYS) was carried (refer 
to MissRaceSex sheet). After this round of collecting on patient gender and race, the data 
was checked on duplicity and 2390 patients were found to have conflicts on duplicated 
entries from MISYS (DuplicateRace&Sex MYSIS sheet).  
The RaceandGender updates in 10-18-2012 was fold in the updates in Spring 
2012 “rawdat.racegenderregdata4_30_2012” by include f nction of 
'V:\ColScope\SCMEC\Data\SASfilz\DA2012\CorrectionCodeForTheRegistry\PatAgeGe
nderRaceCorrectionCode SCMEC 10-17-2012.sas'(n=2722) and 
'V:\ColScope\SCMEC\Data\SASfilz\DA2012\CorrectionCodeForTheRegistry\PatGender
RaceCorrectionCode.sas'(n=2714), output as “RaceAndGender”. “RaceAndGender” was 
later merged in “Colonoscopy4” and output as final permanent product of “Colonoscopy 
Data.sas” as “rawdat.FinalColonoscopy2012”. 
V:\ColScope\SCMEC\Data\SASfilz\DA2012\ Combine polyp and procedure datasets 10-
17-2012.sas 
Final product of Polyp Data 10-17-12.sas of “rawdat.finalpolyps2012” and 
Colonoscopy Data.sas of “rawdat.FinalColonoscopy2012” were read in. 




2. ReferalReason and HistColSurgDis updates were fold in 
“rawdat.FinalColonoscopy2012” by include function of 
‘V:\ ColScope\SCMEC\Data\SASfilz\DA2012\CorrectionCodeForTheRegistry\Re
feralReason_HistColSurgDisCorrectionCode07252012.sas'. 
3. Identify subjects with multiple procedures using frequency function in 
“rawdat.finalcolonoscopy2012” to count the number of procedure for each 
patientid and output as “MultiCol”. Merged “MultiCol” back into 
“rawdat.finalcolonoscopy2012” by patientid to identify he “FirstProcedure” and 
“RepeatCol” variables using first.id function and count product, output as 
“Procedures2”. 
4. “SumPolyps” and “SumPolypTypes” were merged with “Procedures2” by 
operationid.  
5. The “referralreasongrp” variable was in a separate d aset called “RawDat.Ref 
(n=456)” and was not read in to “analytic.UpdatedRevProcFinalOct192012”, so 
bring them in here, then manually applied 10 corrections made from “Surgical 
referrals 10262011+ History Colon.xlsx”. 
6. Output as “analytic.UpdatedRevPolypFinalOct192012” and 
“analytic.UpdatedRevProcFinalOct192012” as final products of polyp and 
procedure datasets for analysis in this study. 
 
E. Defining the key variables of interest 
The question to be answered in this research is the creening colonoscopy quality. 
Adenoma detection is our key dependent variable to define the quality. To define the 
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adenoma, endoscopists first find the polyps during the colonoscopy, classify the polyp by 
its appearance, and take part of the lesion to lab for iopsy to confirm the histology of the 
polyp. Therefore, we first look at polyp detection a d go to adenoma detection as our 
main interest variable.  
Polyp detection rate is defined as the percentage of patients with at least one 
polyp was found. Each polyp has a polypid and a procedureid to link to the patient it 
belongs to. To identify the patient with polyp or not, we summarize the polyp by 
patientid in polyp dataset. If the patientid exist in the poly  summary dataset, the patient 
was coded as “Yes” in polyps column in procedure dataset, and vice versa. To calculate 
polyp detection rate, patients with polyps equal to “Yes” are divided by total patients. 
Adenoma detection rate follows the same logic when cr ating. 
data SCMECProcPolyp1 (drop=polres rename=(pcp=ProviderID)) polyponly; 
merge Procedures2 ( in=inprocs ) 
      SumPolypTypes (in=inPolpyps)  
      SumPolyps (rename=(count=SumPolyps) drop=percent); 
by operationid; 
ProcedureId=operationid; 
  **  create polyps yn  **; 
if  inprocs and inPolpyps then polyps=1; else polyps=0; format polyps yn.; 
  **  add missing to polyp level histology  **; 
if  polyps eq 0 then  
  Do;  
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    SumPolyps=0; SumAdenoma=0; SumAdvAdenoma=0; SumSerratedAd=0; 
SumHyperPolyp=0; SumNormoPolyp=0; SumCarcinoid=0; SumCarcinoma=0; 
SumAdvNeoplasm=0; 
  End; 
else if  polres eq . then  
  Do;  
   SumPolyps=.m; SumAdenoma=.m; SumAdvAdenoma=.m; SumSerratedAd=.m; 
SumHyperPolyp=.m; SumNormoPolyp=.m; SumCarcinoid=.m; SumCarcinoma=.m; 
SumAdvNeoplasm=.m; 
  End; 
For the number of polyps found per subject, the polyp was summarized by 
patientid in polyp dataset and the exact number of count was merged into procedure 
dataset as SumPolyps by patientid, as well as the number of adenomas found per subject, 
named SumAdenomas. 
proc freq data=SCMECpolyps noprint; 
tables operationid/out=SumPolyps; 
run ; 
proc sort data=SCMECpolyps; by operationid; 
proc summary data=SCMECpolyps noprint; 
var  CountPolyp Adenoma AdvAdenoma SerratedAdenoma HyperPolyp NormoPolyp 
Carcinoid Carcinoma AdvNeoplasm PolypQuantity Polyp_result; 
output out=SumPolypTypes (drop=_type_ _freq_) 
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sum = SumPolyps SumAdenoma SumAdvAdenoma SumSerratedAd SumHyperPolyp 




The protocol type is classified based on providerID from SCMEC, providerID 
equal to 56 and 64 were classified as 1-person technique specialists, whereas providerID 
equal to 1, 22 and 59 were classified as 2-person technique specialists, and remaining 
procedures are all 2-person technique PCPs. 
     if  ProviderID in (56,64) then protocol=1;*56=Kudchadkar, 64=Sweeney (n=604); 
else if  ProviderID  in (1,22,59)   then protocol=2;*1=Lloyd, 22=Minhas, 59=Yunis 
(n=4742); 
else protocol=3;* PCP (n=15224); 
format protocol protocol.; 
proc format  library=library; 
value protocol  1 = '1-person Specialist' 
                2 = '2-person Specialist' 
                3 = '2-person PCP'; 
run ; 
The sedation type is categorized by procedure date,every procedure conducted 
prior April 1, 2006 was categorized as Midazolam-meperdine sedated procedure, while 
the counter part of the procedure dataset was coded as propofol sedated procedure. 




format Anesthesia Anesthesia.; 
proc format  library=library; 
value Anesthesia 0='Dermol' 
                 1='Propofol'; 
run ; 
 
